UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2015
Commission file number 1-34435
EMDEON INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware | 20-5799664 | |
(State or Other Jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification No.) | |
3055 Lebanon Pike, Suite 1000 Nashville, TN |
37214 | |
(Address of Principal Executive Offices) | (Zip Code) |
(615) 932-3000
(Registrants Telephone Number, Including Area Code)
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ¨ No x*
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer | ¨ | Accelerated filer | ¨ | |||
Non-accelerated filer | x (Do not check if a smaller reporting company) | Smaller reporting company | ¨ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
Indicate the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date:
Class |
Outstanding as of November 6, 2015 | |
Common Stock, $0.01 par value | 100 |
* | The registrant is a voluntary filer of certain reports required to be filed by companies under Section 13 or 15(d) of the Securities and Exchange Act of 1934 and has filed all reports that would have been required to have been filed by the registrant during the preceding 12 months had it been subject to such filing requirements during the entirety of such period. |
Table of Contents
PART I. | FINANCIAL INFORMATION |
ITEM 1. | FINANCIAL STATEMENTS |
Emdeon Inc.
Condensed Consolidated Balance Sheets
(unaudited and amounts in thousands, except share and per share amounts)
September 30, 2015 |
December 31, 2014 |
|||||||
ASSETS | ||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 84,958 | $ | 82,306 | ||||
Accounts receivable, net of allowance for doubtful accounts of $4,425 and $6,377 at September 30, 2015 and December 31, 2014, respectively |
278,826 | 233,791 | ||||||
Deferred income tax assets |
15,457 | 18,893 | ||||||
Prepaid expenses and other current assets |
34,354 | 29,246 | ||||||
|
|
|
|
|||||
Total current assets |
413,595 | 364,236 | ||||||
Property and equipment, net |
299,035 | 244,153 | ||||||
Goodwill |
2,291,375 | 1,702,569 | ||||||
Intangible assets, net |
1,694,838 | 1,539,394 | ||||||
Other assets, net |
8,041 | 9,183 | ||||||
|
|
|
|
|||||
Total assets |
$ | 4,706,884 | $ | 3,859,535 | ||||
|
|
|
|
|||||
LIABILITIES AND EQUITY | ||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 27,265 | $ | 16,399 | ||||
Accrued expenses |
209,104 | 175,206 | ||||||
Deferred revenues |
12,005 | 10,518 | ||||||
Current portion of long-term debt |
31,265 | 27,308 | ||||||
|
|
|
|
|||||
Total current liabilities |
279,639 | 229,431 | ||||||
Long-term debt, excluding current portion |
2,750,330 | 2,135,468 | ||||||
Deferred income tax liabilities |
448,929 | 413,227 | ||||||
Tax receivable agreement obligations to related parties |
179,237 | 163,983 | ||||||
Other long-term liabilities |
9,044 | 15,361 | ||||||
Commitments and contingencies |
||||||||
Equity: |
||||||||
Common stock (par value, $.01), 100 shares authorized and outstanding at September 30, 2015 and December 31, 2014, respectively |
| | ||||||
Additional paid-in capital |
1,318,704 | 1,149,360 | ||||||
Accumulated other comprehensive income (loss) |
(2,931 | ) | (1,955 | ) | ||||
Accumulated deficit |
(276,068 | ) | (245,340 | ) | ||||
|
|
|
|
|||||
Total equity |
1,039,705 | 902,065 | ||||||
|
|
|
|
|||||
Total liabilities and equity |
$ | 4,706,884 | $ | 3,859,535 | ||||
|
|
|
|
See accompanying notes to unaudited condensed consolidated financial statements.
3
Emdeon Inc.
Condensed Consolidated Statements of Operations
(unaudited and amounts in thousands)
Three Months Ended September 30, 2015 |
Three Months Ended September 30, 2014 |
Nine Months Ended September 30, 2015 |
Nine Months Ended September 30, 2014 |
|||||||||||||
Revenue: |
||||||||||||||||
Solutions revenue |
$ | 287,946 | $ | 255,015 | $ | 810,162 | $ | 740,226 | ||||||||
Postage revenue |
89,839 | 86,593 | 268,119 | 256,747 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total revenue |
377,785 | 341,608 | 1,078,281 | 996,973 | ||||||||||||
Costs and expenses: |
||||||||||||||||
Cost of operations (exclusive of depreciation and amortization below) |
129,385 | 116,909 | 371,859 | 344,741 | ||||||||||||
Development and engineering |
11,651 | 8,117 | 32,600 | 24,084 | ||||||||||||
Sales, marketing, general and administrative |
56,719 | 43,873 | 151,955 | 147,781 | ||||||||||||
Customer postage |
89,839 | 86,593 | 268,119 | 256,747 | ||||||||||||
Depreciation and amortization |
85,817 | 48,448 | 183,446 | 141,541 | ||||||||||||
Accretion |
6,458 | 4,452 | 15,254 | 9,220 | ||||||||||||
Impairment of long-lived assets |
219 | 3,114 | 1,180 | 82,689 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating income (loss) |
(2,303 | ) | 30,102 | 53,868 | (9,830 | ) | ||||||||||
Interest expense, net |
45,541 | 36,635 | 121,685 | 109,741 | ||||||||||||
Contingent consideration |
(4,660 | ) | 1,976 | (4,825 | ) | 3,646 | ||||||||||
Other |
| | | (3,968 | ) | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income (loss) before income tax provision (benefit) |
(43,184 | ) | (8,509 | ) | (62,992 | ) | (119,249 | ) | ||||||||
Income tax provision (benefit) |
(10,278 | ) | 4,493 | (32,264 | ) | (43,733 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income (loss) |
$ | (32,906 | ) | $ | (13,002 | ) | $ | (30,728 | ) | $ | (75,516 | ) | ||||
|
|
|
|
|
|
|
|
See accompanying notes to unaudited condensed consolidated financial statements.
4
Emdeon Inc.
Condensed Consolidated Statements of Comprehensive Income (Loss)
(unaudited and amounts in thousands)
Three Months Ended September 30, 2015 |
Three Months Ended September 30, 2014 |
Nine Months Ended September 30, 2015 |
Nine Months Ended September 30, 2014 |
|||||||||||||
Net income (loss) |
$ | (32,906 | ) | $ | (13,002 | ) | $ | (30,728 | ) | $ | (75,516 | ) | ||||
Other comprehensive income (loss): |
||||||||||||||||
Changes in fair value of interest rate swap, net of taxes |
6 | 732 | (445 | ) | (127 | ) | ||||||||||
Foreign currency translation adjustment |
(347 | ) | (127 | ) | (531 | ) | (100 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Other comprehensive income (loss) |
(341 | ) | 605 | (976 | ) | (227 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Total comprehensive income (loss) |
$ | (33,247 | ) | $ | (12,397 | ) | $ | (31,704 | ) | $ | (75,743 | ) | ||||
|
|
|
|
|
|
|
|
See accompanying notes to unaudited condensed consolidated financial statements.
5
Emdeon Inc.
Condensed Consolidated Statements of Equity
(unaudited and amounts in thousands, except share amounts)
Common Stock | Additional Paid-in Capital |
Accumulated Deficit |
Accumulated Other Comprehensive Income (Loss) |
Total Equity |
||||||||||||||||||||
Shares | Amount | |||||||||||||||||||||||
Balance at January 1, 2014 |
100 | $ | | $ | 1,139,375 | $ | (169,486 | ) | $ | (1,343 | ) | $ | 968,546 | |||||||||||
Equity compensation expense |
| | 5,914 | | | 5,914 | ||||||||||||||||||
Issuance of shares in connection with equity compensation plans, net of taxes |
| | 1,257 | | | 1,257 | ||||||||||||||||||
Repurchase of Parent common stock |
| | (960 | ) | | | (960 | ) | ||||||||||||||||
Capital contribution from Parent |
| | 2,000 | | | 2,000 | ||||||||||||||||||
Net income (loss) |
| | | (75,516 | ) | | (75,516 | ) | ||||||||||||||||
Foreign currency translation adjustment |
| | | | (100 | ) | (100 | ) | ||||||||||||||||
Change in fair value of interest rate swap, net of taxes |
| | | | (127 | ) | (127 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Balance at September 30, 2014 |
100 | $ | | $ | 1,147,586 | $ | (245,002 | ) | $ | (1,570 | ) | $ | 901,014 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Balance at January 1, 2015 |
100 | $ | | $ | 1,149,360 | $ | (245,340 | ) | $ | (1,955 | ) | $ | 902,065 | |||||||||||
Equity compensation expense |
| | 6,814 | | | 6,814 | ||||||||||||||||||
Issuance of shares in connection with equity compensation plans, net of taxes |
| | 305 | | | 305 | ||||||||||||||||||
Capital contribution from Parent |
| | 166,576 | | | 166,576 | ||||||||||||||||||
Repurchase of Parent common stock |
| | (4,351 | ) | | | (4,351 | ) | ||||||||||||||||
Net income (loss) |
| | | (30,728 | ) | | (30,728 | ) | ||||||||||||||||
Foreign currency translation adjustment |
| | | | (531 | ) | (531 | ) | ||||||||||||||||
Change in fair value of interest rate swap, net of taxes |
| | | | (445 | ) | (445 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Balance at September 30, 2015 |
100 | $ | | $ | 1,318,704 | $ | (276,068 | ) | $ | (2,931 | ) | $ | 1,039,705 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to unaudited condensed consolidated financial statements.
6
Emdeon Inc.
Condensed Consolidated Statements of Cash Flows
(unaudited and amounts in thousands)
Nine Months Ended September 30, 2015 |
Nine Months Ended September 30, 2014 |
|||||||
Operating activities |
||||||||
Net income (loss) |
$ | (30,728 | ) | $ | (75,516 | ) | ||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
||||||||
Depreciation and amortization |
183,446 | 141,541 | ||||||
Accretion |
15,254 | 9,220 | ||||||
Equity compensation |
6,814 | 5,914 | ||||||
Deferred income tax expense (benefit) |
(28,837 | ) | (44,886 | ) | ||||
Amortization of debt discount and issuance costs |
7,441 | 5,804 | ||||||
Contingent consideration |
(4,825 | ) | 3,646 | |||||
Impairment of long-lived assets |
1,180 | 82,689 | ||||||
Other |
(1,474 | ) | (3,125 | ) | ||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
6,147 | (12,656 | ) | |||||
Prepaid expenses and other |
(11,674 | ) | (4,490 | ) | ||||
Accounts payable |
10,517 | 644 | ||||||
Accrued expenses, deferred revenue and other liabilities |
(918 | ) | (375 | ) | ||||
|
|
|
|
|||||
Net cash provided by (used in) operating activities |
152,343 | 108,410 | ||||||
|
|
|
|
|||||
Investing activities |
||||||||
Purchases of property and equipment |
(39,175 | ) | (37,673 | ) | ||||
Payments for acquisitions, net of cash acquired |
(717,669 | ) | (87,909 | ) | ||||
Other |
(3,676 | ) | (97 | ) | ||||
|
|
|
|
|||||
Net cash provided by (used in) investing activities |
(760,520 | ) | (125,679 | ) | ||||
|
|
|
|
|||||
Financing activities |
||||||||
Proceeds from Term Loan Facility |
385,411 | | ||||||
Proceeds from Senior Notes |
243,453 | | ||||||
Proceeds from Revolving Facility |
60,000 | 65,000 | ||||||
Payments on Revolving Facility |
(60,000 | ) | (65,000 | ) | ||||
Payments on Term Loan Facility |
(11,870 | ) | (9,659 | ) | ||||
Payment of debt assumed from acquisition |
(154,469 | ) | (23,262 | ) | ||||
Deferred financing obligation payments |
(6,173 | ) | (4,717 | ) | ||||
Repurchase of Parent common stock |
(4,351 | ) | (960 | ) | ||||
Capital contribution from Parent |
166,881 | 3,256 | ||||||
Payment of Contingent Consideration |
(5,553 | ) | | |||||
Other |
(2,500 | ) | | |||||
|
|
|
|
|||||
Net cash provided by (used in) financing activities |
610,829 | (35,342 | ) | |||||
|
|
|
|
|||||
Net increase (decrease) in cash and cash equivalents |
2,652 | (52,611 | ) | |||||
Cash and cash equivalents at beginning of period |
82,306 | 76,538 | ||||||
|
|
|
|
|||||
Cash and cash equivalents at end of period |
$ | 84,958 | $ | 23,927 | ||||
|
|
|
|
See accompanying notes to unaudited condensed consolidated financial statements.
7
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
1. Nature of Business and Organization
Nature of Business
Emdeon Inc. (the Company), through its subsidiaries, is a provider of software and analytics, network solutions and technology-enabled services that optimize communications, payments and actionable insights by leveraging its intelligent healthcare platform, which includes the single largest financial and administrative network in the United States healthcare system. The Companys platform and solutions integrate and automate key functions of its payer, provider and pharmacy customers throughout the patient encounter, from consumer engagement and pre-care eligibility and enrollment through payment.
Organization
The Company was formed as a Delaware limited liability company in September 2006 and converted into a Delaware corporation in September 2008 in anticipation of the Companys August 2009 initial public offering (the IPO).
On November 2, 2011, pursuant to an Agreement and Plan of Merger among the Company, Beagle Parent Corp. (Parent) and Beagle Acquisition Corp. (Merger Sub), Merger Sub merged with and into the Company with the Company surviving the merger (the Merger). Subsequent to the Merger, the Company became an indirect wholly-owned subsidiary of Parent, which is controlled by affiliates of The Blackstone Group L.P. (Blackstone).
2. Basis of Presentation
Principles of Consolidation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (GAAP) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the Securities and Exchange Commission (SEC) Guidelines, Rules and Regulations (Regulation S-X) and, in the opinion of management, reflect all normal recurring adjustments necessary for a fair presentation of results for the unaudited interim periods presented. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. The results of operations for the interim period are not necessarily indicative of the results to be obtained for the full fiscal year. All material intercompany accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.
Reclassifications
Certain reclassifications have been made to the prior period financial statements to conform to the current period presentation.
Effective January 1, 2015, the Company completed an internal reorganization of its reporting structure which resulted in a change in the composition of its reportable segments to software and analytics, network solutions and technology-enabled services. Prior period segment information has been restated to reflect the current organizational structure.
Effective January 1, 2015, in order to clarify the nature of its customer related postage activities, the Company also created separate captions on the statement of operations within revenue and costs and expenses, respectively. Previously, such amounts were included within revenue and costs of operations. To conform to the current period presentation, costs of operations were reduced by $86,593 and $256,747 and reclassified as customer postage for the three and nine months ended September 30, 2014, respectively.
Accounting Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company bases its estimates on historical experience, current business factors and various other assumptions that the Company believes are necessary to consider in order to form a basis for making judgments about the carrying values of assets and liabilities, the recorded amounts of revenue and expenses and disclosure of contingent assets and liabilities. The Company is subject to uncertainties such as the impact of future events, economic, environmental and political factors and changes in the Companys business environment; therefore, actual results could differ materially from these estimates. Accordingly, the
8
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
accounting estimates used in the preparation of the Companys financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Companys operating environment changes. Changes in estimates are made when circumstances warrant. Such changes in estimates and refinements in estimation methodologies are reflected in the reported results of operations; and if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements. Estimates and assumptions by management affect: the allowance for doubtful accounts; the fair value assigned to assets acquired and liabilities assumed in business combinations; tax receivable agreement obligations; the fair value of interest rate swap obligations; contingent consideration; loss accruals; the carrying value of long-lived assets (including goodwill and intangible assets); the amortization period of long-lived assets (excluding goodwill); the carrying value, capitalization and amortization of software development costs; the provision and benefit for income taxes and related deferred tax accounts; certain accrued expenses; revenue recognition; contingencies; and the value attributed to equity awards.
Recent Accounting Pronouncements
In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, which replaces most prior general and industry specific revenue recognition guidance with a principles-based comprehensive revenue recognition framework. Under this revised framework, a company will recognize revenue to depict the transfer of promised goods and services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. This update is effective for fiscal years and interim periods beginning in those years after December 15, 2017. Early adoption is permitted in years beginning after December 15, 2016. Upon adoption, a company may elect to either retrospectively restate each prior reporting period or reflect the cumulative effect of initially applying the update with an adjustment to retained earnings. The Company is currently assessing the potential effects this update may have on its consolidated financial statements.
In June 2014, the FASB issued ASU No. 2014-12, which clarifies, in the context of share-based payment awards, that a performance target that affects vesting and could be achieved after the requisite service period has been rendered should be treated as a performance condition. Prior to this update, because there was no explicit guidance, there was diversity in practice among companies. This update is effective for fiscal years and interim periods within those years beginning after December 15, 2015, with early adoption permitted. The Company does not expect the adoption of this update to have a material effect on its consolidated financial statements.
In January 2015, the Company adopted FASB ASU No. 2014-08, which changes the requirements for reporting discontinued operations. Following adoption of this update, discontinued operations generally will be reported for the disposal by sale or otherwise of a component or a group of components that represents a strategic shift that has or will have a major effect on an entitys operations and financial results. Upon adoption, this update had no effect on the Companys consolidated financial statements
In July 2015, the Company adopted ASU No. 2015-03, which generally requires that debt issue costs related to a debt liability be presented on the balance sheet as a direct deduction from the carrying amount of that debt liability. As a result of the adoption of this update, the Company retrospectively adjusted its consolidated balance sheet as of December 31, 2014 to reduce other assets and long-term debt, excluding current portion, by $11,128.
In July 2015, the Company adopted ASU No. 2015-05, which provides guidance to customers about whether a cloud computing arrangement includes a software license and requires that all software licenses utilized in internal use software arrangements be accounted for consistent with other licenses of intangible assets. As a result of the adoption of this update, the Company will recognize new or materially modified software licenses within intangible assets on its consolidated balance sheet and will recognize the related amortization of these intangible assets within amortization expense. The Company does not expect the adoption of this update to have a material effect on its consolidated financial statements.
In September 2015, the FASB issued ASU No. 2015-16, which simplifies the accounting for measurement period adjustments in connection with business combinations. Following the adoption of this update, the Company will recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. This update is effective for fiscal years and interim periods beginning in those years after December 15, 2015. The Company does not expect the adoption of this update to have a material effect on its consolidated financial statements.
9
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
3. Concentration of Credit Risk
The Companys revenue is primarily generated in the United States. Changes in economic conditions, government regulations or demographic trends, among other matters, in the United States could adversely affect the Companys revenue and results of operations.
The Company maintains its cash and cash equivalent balances in either insured depository accounts or money market mutual funds. The money market mutual funds are limited to investments in low-risk securities such as United States or government agency obligations, or repurchase agreements secured by such securities.
4. Business Combinations
In July 2014, the Company acquired all of the equity interests of Capario, Inc. (Capario), a technology-enabled provider of revenue cycle management solutions.
In November 2014, the Company acquired all of the equity interests of Change Healthcare Corporation (Change), a technology-enabled provider of healthcare consumer engagement and transparency solutions.
In December 2014, the Company acquired all of the equity interests of Adminisource Communications, Inc. (Adminisource), a technology-enabled provider of payment and communication solutions.
In August 2015, the Company acquired all of the equity interests of Altegra Health, Inc. (Altegra), a technology-enabled provider that assists payers and risk bearing providers with analytics and reporting capabilities for risk adjustment, member engagement and quality analysis to achieve actionable insights and improved management for value-based healthcare.
The following table summarizes certain information related to these acquisitions. The preliminary values of the consideration transferred, assets acquired and liabilities assumed in the Altegra acquisition, including the related tax effects, are subject to receipt of a final valuation and working capital settlement.
10
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
Altegra | Adminisource | Change | Capario | |||||||||||||
Total Consideration Fair Value at Acquisition Date: |
||||||||||||||||
Cash paid at closing |
$ | 735,669 | $ | 34,825 | $ | 138,329 | $ | 89,423 | ||||||||
Contingent consideration |
| | 4,730 | | ||||||||||||
Parent options fair value |
| | 650 | | ||||||||||||
Other |
(203 | ) | (925 | ) | 80 | (219 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 735,466 | $ | 33,900 | $ | 143,789 | $ | 89,204 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Allocation of the Consideration Transferred: |
||||||||||||||||
Cash |
$ | 17,176 | $ | | $ | 8,053 | $ | 2,292 | ||||||||
Accounts receivable |
52,014 | 6,474 | 335 | 4,839 | ||||||||||||
Deferred income tax assets |
1,625 | 3,797 | 9,170 | 275 | ||||||||||||
Prepaid expenses and other current assets |
4,730 | 466 | 397 | 1,113 | ||||||||||||
Property and equipment |
86,901 | 874 | 7,953 | 9,580 | ||||||||||||
Identifiable intangible assets: |
||||||||||||||||
Tradename |
11,535 | 108 | 5,300 | 900 | ||||||||||||
Noncompetition agreements |
5,041 | | 2,840 | 2,740 | ||||||||||||
Customer relationships |
251,099 | 21,230 | 4,430 | 38,510 | ||||||||||||
Other |
633 | | | | ||||||||||||
Goodwill |
593,552 | 3,223 | 109,994 | 76,279 | ||||||||||||
Accounts payable |
(837 | ) | (279 | ) | (174 | ) | (2,270 | ) | ||||||||
Accrued expenses |
(52,147 | ) | (1,993 | ) | (2,203 | ) | (8,818 | ) | ||||||||
Deferred revenues |
(5,100 | ) | (306 | ) | (2 | ) | ||||||||||
Current maturities of long-term debt |
| | | (2,600 | ) | |||||||||||
Deferred income tax liabilities |
(76,287 | ) | | | (14,642 | ) | ||||||||||
Long-term debt |
(154,469 | ) | | (2,000 | ) | (18,785 | ) | |||||||||
Other long-term liabilities |
| | | (207 | ) | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total consideration transferred |
$ | 735,466 | $ | 33,900 | $ | 143,789 | $ | 89,204 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Acquisition costs in sales, marketing, general and administrative expense: |
||||||||||||||||
For the three months ended September 30, 2015 |
$ | 2,936 | $ | | $ | | $ | | ||||||||
For the three months ended September 30, 2014 |
$ | | $ | | $ | | $ | 234 | ||||||||
For the nine months ended September 30, 2015 |
$ | 4,599 | $ | | $ | | $ | | ||||||||
For the nine months ended September 30, 2014 |
$ | | $ | | $ | | $ | 862 |
11
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
Altegra | Adminisource | Change | Capario | |||||||||||||
Other Information: |
||||||||||||||||
Gross contractual accounts receivable |
$ | 53,108 | $ | 7,521 | $ | 335 | $ | 5,112 | ||||||||
Amount not expected to be collected |
$ | 1,094 | $ | 1,047 | $ | | $ | 273 | ||||||||
Goodwill expected to be deductible for tax purposes |
$ | | $ | | $ | | $ | | ||||||||
Contingent Consideration Information: |
||||||||||||||||
Contingent consideration range |
N/A | N/A | $0-$50,000 | N/A | ||||||||||||
Measurement period |
N/A | N/A | |
January 1, 2015 to December 31, 2017 |
|
N/A | ||||||||||
Basis of measurement |
N/A | N/A | |
Revenue performance |
|
N/A | ||||||||||
Type of measurement |
N/A | N/A | Level 3 | N/A | ||||||||||||
Key assumptions at the acquisition date: |
||||||||||||||||
Range of annual revenue performance |
N/A | N/A | $5,516-$51,376 | N/A | ||||||||||||
Expected payment date(s) |
N/A | N/A | 2016-2018 | N/A | ||||||||||||
Discount rate(s) |
N/A | N/A | 10.5% to 11.3% | N/A | ||||||||||||
Increase (decrease) to net loss: |
||||||||||||||||
For the three months ended September 30, 2015 |
N/A | N/A | $(4,660) | N/A | ||||||||||||
For the nine months ended September 30, 2015 |
N/A | N/A | $(4,730) | N/A |
The Company generally recognizes goodwill attributable to the assembled workforce and expected synergies among the operations of the acquired entities and the Companys existing operations. In the case of the Companys acquisitions of operating companies, synergies generally have resulted from the elimination of duplicative facilities and personnel costs and cross selling opportunities among the Companys existing customer base. Goodwill is generally deductible for federal income tax purposes when a business combination is treated as an asset purchase. Goodwill is generally not deductible for federal income tax purposes when the business combination is treated as a stock purchase.
12
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
5. Goodwill and Intangible Assets
The following table presents the changes in the carrying amount of goodwill for the indicated periods.
Software and Analytics |
Network Solutions | Technology-enabled Services |
Total | |||||||||||||
Balance at December 31, 2014 |
$ | 581,533 | $ | 620,805 | $ | 500,231 | $ | 1,702,569 | ||||||||
Acquisitions |
593,552 | | | 593,552 | ||||||||||||
Other |
(3,944 | ) | | (802 | ) | (4,746 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Balance at September 30, 2015 |
$ | 1,171,141 | $ | 620,805 | $ | 499,429 | $ | 2,291,375 | ||||||||
|
|
|
|
|
|
|
|
Intangible assets subject to amortization as of September 30, 2015 consisted of the following:
Weighted Average Remaining Life |
Gross Carrying Amount |
Accumulated Amortization |
Net | |||||||||||||
Customer relationships |
13.8 | $ | 1,878,991 | $ | (322,949 | ) | $ | 1,556,042 | ||||||||
Tradenames |
0.3 | 174,381 | (63,106 | ) | 111,275 | |||||||||||
Non-compete agreements |
1.7 | 25,021 | (13,836 | ) | 11,185 | |||||||||||
Data sublicense agreement |
2.0 | 31,000 | (20,512 | ) | 10,488 | |||||||||||
Other |
2.0 | 6,960 | (1,112 | ) | 5,848 | |||||||||||
|
|
|
|
|
|
|||||||||||
Total |
$ | 2,116,353 | $ | (421,515 | ) | $ | 1,694,838 | |||||||||
|
|
|
|
|
|
Amortization expense was $115,970 and $75,286 for the nine months ended September 30, 2015 and 2014, respectively. The Company recently announced its plan to rebrand as Change HealthcareTM beginning in the fourth quarter of 2015. As a result of this plan, the Company revised the remaining useful life of its existing tradename asset. During the three months ended September 30, 2015, the Company recognized amortization expense of $31,525 related to its existing tradename asset.
Aggregate future amortization expense for intangible assets is estimated to be:
Remainder of 2015 |
$ | 127,495 | ||
2016 |
129,950 | |||
2017 |
123,895 | |||
2018 |
117,843 | |||
2019 |
113,954 | |||
Thereafter |
1,081,701 | |||
|
|
|||
$ | 1,694,838 | |||
|
|
6. Long-Term Debt
The Companys long-term indebtedness is comprised of a senior secured term loan facility (as amended, the Term Loan Facility), a revolving credit facility (the Revolving Facility; together with the Term Loan Facility, the Senior Credit Facilities), 11% senior notes due 2019 (the 2019 Notes), 11.25% senior notes due 2020 (the 2020 Notes) and 6% senior notes due 2021 (the 2021 Notes; together with the 2019 Notes and 2020 Notes, the Senior Notes).
13
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
Long-term debt as of September 30, 2015 and December 31, 2014, consisted of the following:
September 30, 2015 |
December 31, 2014 |
|||||||
Senior Credit Facilities |
||||||||
$1,696 million Senior Secured Term Loan facility, due November 2, 2018, net of unamortized discount of $25,499 and $20,016 at September 30, 2015 and December 31, 2014, respectively (effective interest rate of 4.29%) |
$ | 1,624,223 | $ | 1,245,376 | ||||
$160 million Senior Secured Term Loan facility, due November 2, 2018, net of unamortized discount of $3,615 and $4,438 at September 30, 2015 and December 31, 2014, respectively (effective interest rate of 4.54%) |
154,785 | 155,162 | ||||||
$125 million Senior Secured Revolving Credit facility, expiring on November 2, 2016 and bearing interest at a variable base rate plus a spread rate |
| | ||||||
Senior Notes |
||||||||
$375 million 11% Senior Notes due December 31, 2019, net of unamortized discount of $6,605 and $7,477 at September 30, 2015 and December 31, 2014, respectively (effective interest rate of 11.53%) |
368,395 | 367,523 | ||||||
$375 million 11.25% Senior Notes due December 31, 2020, net of unamortized discount of $8,778 and $9,651 at September 30, 2015 and December 31, 2014, respectively (effective interest rate of 11.85%) |
366,222 | 365,349 | ||||||
$250 million 6% Senior Notes due February 15, 2021, net of unamortized discount of $6,412 and $0 at September 30, 2015 and December 31, 2014, respectively (effective interest rate of 6.57%) |
243,588 | | ||||||
Obligation under data sublicense agreement |
17,237 | 17,237 | ||||||
Other |
7,145 | 12,129 | ||||||
Less current portion |
(31,265 | ) | (27,308 | ) | ||||
|
|
|
|
|||||
Long-term debt |
$ | 2,750,330 | $ | 2,135,468 | ||||
|
|
|
|
Senior Credit Facilities
The credit agreement governing the Senior Credit Facilities (the Senior Credit Agreement) provides that, subject to certain conditions, the Company may request additional tranches of term loans, increase commitments under the Revolving Facility or the Term Loan Facility or add one or more incremental revolving credit facility tranches (provided that the revolving credit commitments outstanding at any time have no more than three different maturity dates) in an aggregate amount not to exceed (a) $300,000 plus (b) an unlimited amount at any time, subject to compliance on a pro forma basis with a first lien net leverage ratio of no greater than 4.00 to 1.00. Availability of such additional tranches of term loans or revolving credit facilities and/or increased commitments is subject to, among other conditions, the absence of any default under the Senior Credit Agreement and the receipt of commitments by existing or additional financial institutions. Proceeds of the Revolving Facility, including up to $30,000 in the form of borrowings on same-day notice, referred to as swingline loans, and up to $50,000 in the form of letters of credits, are available to provide financing for working capital and general corporate purposes.
Borrowings under the Senior Credit Facilities bear interest at an annual rate equal to an applicable margin plus, at the Companys option, either (a) a base rate determined by reference to the highest of (i) the applicable prime rate, (ii) the federal funds rate plus 0.50% and (iii) a LIBOR rate determined by reference to the costs of funds for United States dollar deposits for an interest period of one month, adjusted for certain additional costs, plus 1.00%, which base rate, in the case of the Term Loan Facility only, shall be no less than 2.25%, or (b) a LIBOR rate determined by reference to the costs of funds for United States dollar deposits for the interest period relevant to such borrowing, adjusted for certain additional costs, which, in the case of the Term Loan Facility only, shall be no less than 1.25%.
In April 2012, the Company amended the Senior Credit Agreement to reprice the Senior Credit Facilities and borrow $80,000 of additional term loans. In April 2013, the Company again amended the Senior Credit Agreement to further reprice, and also to modify certain financial covenants under the Senior Credit Facilities. Following the April 2013 amendment, the interest rate on both the Term Loan Facility and Revolving Facility is LIBOR plus 2.50%. The Term Loan Facility remains subject to a LIBOR floor of 1.25%, and there continues to be no LIBOR floor on the Revolving Facility. In connection with
14
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
the April 2013 repricing, the Senior Credit Agreement also was amended to, among other things, eliminate the financial covenant related to the consolidated cash interest coverage ratio and modify the financial covenant related to the net leverage test by maintaining the required first lien net leverage ratio at 5.35 to 1.00 for the remaining term of the Senior Credit Facilities.
In December 2014 and August 2015, through further amendments to the Senior Credit Agreement, the Company borrowed an additional $160,000 and $395,000, respectively, under incremental term loan facilities on identical terms and having the same rights and obligations as the existing term loans under the Senior Credit Agreement.
In addition to paying interest on outstanding principal under the Senior Credit Facilities, the Company is required to pay customary agency fees, letter of credit fees and a 0.50% commitment fee in respect of the unutilized commitments under the Revolving Facility.
The Senior Credit Agreement requires that the Company prepay outstanding loans under the Term Loan Facility, subject to certain exceptions, with (a) 100% of the net cash proceeds of any incurrence of debt other than debt permitted under the Senior Credit Agreement, (b) 50% (which percentage will be reduced to 25% and 0% based on the Companys first lien net leverage ratio) of the Companys annual excess cash flow and (c) 100% of the net cash proceeds of certain asset sales and casualty and condemnation events, subject to reinvestment rights and certain other exceptions.
The Company generally may voluntarily prepay outstanding loans under the Senior Credit Facilities at any time without premium or penalty other than breakage costs with respect to LIBOR loans.
The Company is required to make quarterly payments equal to 0.25% of the aggregate principal amount of the loans under the Term Loan Facility, with the balance due and payable on November 2, 2018. Any principal amount outstanding under the Revolving Facility is due and payable on November 2, 2016.
Certain of the Companys United States wholly-owned restricted subsidiaries, together with the Company, are co-borrowers and jointly and severally liable for all obligations under the Senior Credit Facilities. Such obligations of the co-borrowers are unconditionally guaranteed by Beagle Intermediate Holdings, Inc. (a direct wholly-owned subsidiary of Parent), the Company and each of its existing and future United States wholly-owned restricted subsidiaries (with certain exceptions including immaterial subsidiaries). These obligations are secured by a perfected security interest in substantially all of the assets of the co-borrowers and guarantors now owned or later acquired, including a pledge of all of the capital stock of the Company and its United States wholly-owned restricted subsidiaries and 65% of the capital stock of its foreign restricted subsidiaries, subject in each case to the exclusion of certain assets and additional exceptions.
The Senior Credit Agreement requires the Company to comply with a maximum first lien net leverage ratio financial maintenance covenant, to be tested on the last day of each fiscal quarter. A breach of the first lien net leverage ratio covenant is subject to certain equity cure rights. In addition, the Senior Credit Facilities contain a number of negative covenants that, among other things and subject to certain exceptions, restrict the Companys ability and the ability of its subsidiaries to:
| incur additional indebtedness or guarantees; |
| incur liens; |
| make investments, loans and acquisitions; |
| consolidate or merge; |
| sell assets, including capital stock of subsidiaries; |
| pay dividends on capital stock or redeem, repurchase or retire capital stock of the Company or any restricted subsidiary; |
| alter the business of the Company; |
| amend, prepay, redeem or purchase subordinated debt; |
| engage in transactions with affiliates; and |
| enter into agreements limiting dividends and distributions of certain subsidiaries. |
15
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
The Senior Credit Agreement also contains certain customary representations and warranties, affirmative covenants and provisions relating to events of default (including upon change of control).
As of September 30, 2015, the Company believes it was in compliance with all of the applicable debt covenants under the Senior Credit Agreement.
Senior Notes
The 2019 Notes bear interest at an annual rate of 11.00% with interest payable semi-annually on June 30 and December 31 of each year. The 2019 Notes mature on December 31, 2019. The 2020 Notes bear interest at an annual rate of 11.25% with interest payable quarterly on March 31, June 30, September 30 and December 31 of each year. The 2020 Notes mature on December 31, 2020. The 2021 Notes bear interest at an annual rate of 6.00% with interest payable semi-annually on April 15 and October 15 of each year, commencing on April 15, 2016. The 2021 Notes mature on February 15, 2021.
The Company may redeem the 2019 Notes, the 2020 Notes or both, in whole or in part, at any time on or after December 31, 2015 at the applicable redemption price, plus accrued and unpaid interest. At any time prior to December 31, 2015, the Company may redeem the 2019 Notes, the 2020 Notes or both, in whole or in part, at its option and on one or more occasions, at a redemption price equal to 100% of the principal amount, plus a make-whole premium and accrued and unpaid interest.
The Company may redeem the 2021 Notes, in whole or in part, at any time on or after August 15, 2017 at the applicable redemption price, plus accrued and unpaid interest. At any time prior to August 15, 2017, the Company may, at its option and on one or more occasions, redeem up to 40% of the aggregate principal amount of the 2021 Notes at a redemption price equal to 100% of the aggregate principal amount, plus a premium and accrued and unpaid interest with the net cash proceeds of certain equity offerings. At any time prior to August 15, 2017, the Company may redeem the 2021 Notes, in whole or in part, at its option and on one or more occasions, at a redemption price equal to 100% of the principal amount, plus a make-whole premium and accrued and unpaid interest.
If the Company experiences specific kinds of changes in control, it must offer to purchase the Senior Notes at a purchase price equal to 101% of the principal amount, plus accrued and unpaid interest.
The Senior Notes are senior unsecured obligations and rank equally in right of payment with all of the Companys existing and future indebtedness and senior in right of payment to all of its existing and future subordinated indebtedness. The Companys obligations under the Senior Notes are guaranteed on a senior basis by all of its existing and subsequently acquired or organized wholly-owned United States restricted subsidiaries that guarantee the Senior Credit Facilities or its other indebtedness or indebtedness of any affiliate guarantor. The Senior Notes and the related guarantees are effectively subordinated to the Companys existing and future secured obligations and that of its affiliate guarantors to the extent of the value of the collateral securing such obligations, and are structurally subordinated to all existing and future indebtedness and other liabilities of any of the Companys subsidiaries that do not guarantee the Senior Notes.
The indentures governing the Senior Notes (the Indentures) contain customary covenants that restrict the ability of the Company and its restricted subsidiaries to:
| pay dividends on capital stock or redeem, repurchase or retire capital stock of the Company, subject to customary exceptions, including compliance with a fixed charge coverage ratio and subject to limitation based on net income generated during the term of the Indentures; |
| incur additional indebtedness or issue certain capital stock; |
| incur certain liens; |
| make investments, loans, advances and acquisitions; |
| consolidate, merge or transfer all or substantially all of their assets and the assets of their subsidiaries; |
| prepay subordinated debt; |
| engage in certain transactions with affiliates; and |
| enter into agreements restricting the subsidiaries ability to pay dividends. |
16
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
The Indentures also contain certain customary affirmative covenants and events of default.
As of September 30, 2015, the Company believes it was in compliance with all of the applicable debt covenants under the Senior Notes.
Obligation Under Data Sublicense Agreement
In 2009 and 2010, the Company acquired certain additional rights to specified uses of its data from the former owner of the Companys business in order to broaden the Companys ability to pursue business intelligence and data analytics solutions for payers and providers. The Company previously licensed exclusive rights to this data to the former owner of the Companys business. In connection with these data rights acquisitions, the Company recorded amortizable intangible assets and corresponding obligations at inception based on the present value of the scheduled annual payments through 2018, which totaled $65,000 in the aggregate (approximately $21,400 remained payable at September 30, 2015). In connection with the Merger, the Company was required to adjust this obligation to its fair value.
Other
From time to time, the Company enters into deferred financing arrangements with certain vendors. The obligations under such arrangements are generally recorded at the present value of the scheduled payments. Such future payments totaled approximately $7,100 at September 30, 2015.
7. Interest Rate Swap
Risk Management Objective of Using Derivatives
The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity and credit risk, primarily by managing the amount, sources and duration of its debt funding and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Companys derivative financial instruments are used to manage differences in the amount, timing and duration of the Companys known or expected cash receipts and its known or expected cash payments principally related to the Companys borrowings.
Cash Flow Hedges of Interest Rate Risk
The Companys objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. During the nine months ended September 30, 2015, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt pursuant to the Term Loan Facility. As of September 30, 2015, the Company had three outstanding interest rate derivatives with a combined notional amount of $640,000 that were designated as cash flow hedges of interest rate risk.
The effective portion of changes in the fair value of derivatives designated and that qualify as cash flow hedges is recorded in accumulated other comprehensive income and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. The ineffective portion of the change in fair value of the derivatives is recognized directly in earnings. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Companys variable-rate debt. During the next twelve months, the Company estimates that an additional $2,575 will be reclassified as an increase to interest expense.
17
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
The following table summarizes the fair value of the Companys derivative instruments at September 30, 2015 and December 31, 2014:
Fair Values of Derivative Instruments Asset (Liability) Derivatives |
||||||||||
Balance Sheet Location |
September 30, 2015 |
December 31, 2014 |
||||||||
Derivatives designated as hedging instruments: |
||||||||||
Interest rate swaps |
Other assets | $ | | $ | 222 | |||||
Interest rate swaps |
Accrued expenses | (1,908 | ) | (2,567 | ) | |||||
Interest rate swaps |
Other long-term liabilities | (1,197 | ) | | ||||||
|
|
|
|
|||||||
$ | (3,105 | ) | $ | (2,345 | ) | |||||
|
|
|
|
Tabular Disclosure of the Effect of Derivative Instruments on the Statement of Operations
The effect of the derivative instruments on the accompanying unaudited condensed consolidated statements of operations for the three and nine months ended September 30, 2015 and 2014, respectively, is summarized in the following table:
Three Months Ended September 30, |
Three Months Ended September 30, |
Nine Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
Derivatives in Cash Flow Hedging Relationships |
||||||||||||||||
Gain/ (loss) related to effective portion of derivative recognized in other comprehensive loss |
$ | (645 | ) | $ | 595 | $ | (2,695 | ) | $ | (2,150 | ) | |||||
|
|
|
|
|
|
|
|
|||||||||
Gain/ (loss) related to effective portion of derivative reclassified from accumulated other comprehensive loss to interest expense |
$ | (652 | ) | $ | (652 | ) | $ | (1,935 | ) | $ | (1,935 | ) | ||||
|
|
|
|
|
|
|
|
Credit Risk-related Contingent Features
The Company has agreements with each of its derivative counterparties that contain a provision where if the Company defaults on any of its indebtedness, including default where repayment of the indebtedness has not been accelerated by the lender, then the Company also could be declared in default on its derivative obligations.
As of September 30, 2015, the termination value of derivatives in a net liability position, which includes accrued interest but excludes any adjustment for nonperformance risk, related to these agreements was $3,809. If the Company had breached any of these provisions at September 30, 2015, the Company could have been required to settle its obligations under the agreements at this termination value. The Company does not offset any derivative instruments and the derivative instruments are not subject to collateral posting requirements.
8. Fair Value Measurements
Assets and Liabilities Measured at Fair Value on a Recurring Basis
The Companys assets and liabilities that are measured at fair value on a recurring basis consist of the Companys derivative financial instruments and contingent consideration associated with business combinations. The table below summarizes these items as of September 30, 2015, aggregated by the level in the fair value hierarchy within which those measurements fall.
18
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
Description |
Balance at September 30, 2015 |
Quoted in Markets Identical (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Unobservable Inputs (Level 3) |
||||||||||||
Interest rate swaps |
$ | (3,105 | ) | $ | | $ | (3,105 | ) | $ | | ||||||
Contingent consideration obligations |
(4,650 | ) | | | (4,650 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | (7,755 | ) | $ | | $ | (3,105 | ) | $ | (4,650 | ) | |||||
|
|
|
|
|
|
|
|
The valuation of the Companys derivative financial instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivative, including the period to maturity, and uses observable market-based inputs, including interest rate curves. The fair value of the interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash payments (or receipts) and the discounted expected variable cash receipts (or payments) using the overnight index swap rate as the discount rate.
The Company incorporates credit valuation adjustments to appropriately reflect both its own nonperformance risk and the respective counterpartys nonperformance risk in the fair value measurements. In adjusting the fair value of its derivative contracts for the effect of nonperformance risk, the Company has considered the impact of netting and any applicable credit enhancements and measures the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.
Although the Company has determined that the majority of the inputs used to value its derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivatives utilize Level 3 inputs to evaluate the likelihood of default by itself and by its counterparties. As of September 30, 2015, the Company determined that the credit valuation adjustments are not significant to the overall valuation of its derivatives. As a result, the Company determined that its derivative valuations in their entirety are classified in Level 2 of the fair value hierarchy.
The valuation of the Companys contingent consideration obligations is estimated as the present value of total expected contingent consideration payments which are determined using a Monte Carlo simulation. This analysis reflects the contractual terms of the purchase agreements and utilizes assumptions with regard to future sales, probabilities of achieving such future sales, the likelihood and timing of expected payments and a discount rate. Significant increases with respect to assumptions as to future sales and probabilities of achieving such future sales would result in a higher fair value measurement, while an increase in the discount rate would result in a lower fair value measurement.
The table below presents a reconciliation of the fair value of the liabilities that use significant unobservable inputs (Level 3).
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
Balance at beginning of period |
$ | (9,310 | ) | $ | (13,169 | ) | $ | (17,486 | ) | $ | (5,484 | ) | ||||
Adjustment of provisional amounts |
| | (50 | ) | | |||||||||||
Issuance of contingent consideration |
| | | (6,015 | ) | |||||||||||
Settlement of contingent consideration |
| | 8,061 | | ||||||||||||
Total changes included in contingent consideration |
4,660 | (1,976 | ) | 4,825 | (3,646 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balance at end of period |
$ | (4,650 | ) | $ | (15,145 | ) | $ | (4,650 | ) | $ | (15,145 | ) | ||||
|
|
|
|
|
|
|
|
During April 2015, the Company exercised its option to terminate all future obligations under the Vieosoft, Inc. (Vieosoft) stock purchase agreement in exchange for a cash payment of $4,650 to the former stockholders of Vieosoft. This termination payment was not accepted and the former stockholders of Vieosoft have filed a lawsuit against the Company. The Company has reflected a liability of $4,650 within accrued expenses on the accompanying condensed consolidated balance sheet as of September 30, 2015.
19
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
As a result of anticipated revenue growth rates during the measurement period, the Company no longer expects that Change will meet the thresholds sufficient to earn additional consideration.
Assets and Liabilities Measured at Fair Value on a Non-recurring Basis
During the nine months ended September 30, 2014, the Companys technology-enabled services segment received notice that its existing contract with a customer would not be renewed in full upon its expiration. As a result, the Company abandoned a customer related project that was under development and assessed the recoverability of the net assets included in the relevant asset group. The Company recognized an impairment charge, measured as of April 30, 2014, to write off the abandoned project and to adjust the carrying value of the asset group to its fair value. This latter impairment charge was generally allocated to the affected long-lived assets on a pro rata basis. Additionally, the Company abandoned certain network solutions and technology-enabled services segment development projects in connection with execution of certain strategic initiatives during the nine months ended September 30, 2014.
The following table summarizes the affected financial statement captions, the allocation of the impairment charges among those captions and provides certain quantitative information associated with the required fair value measurements for the nine months ended September 30, 2014.
Range of Inputs | Fair Value | Impairment | ||||||||
Long-lived assets to be held and used (Level 3) |
||||||||||
Relevant asset group |
N/A | $ | 13,066 | $ | 73,220 | |||||
Balance sheet account: |
||||||||||
Customer relationships |
N/A | N/A | $ | 72,290 | ||||||
Property and equipment |
N/A | N/A | $ | 930 | ||||||
Unobservable inputs (discounted cash flow method): |
||||||||||
Probability of contract extension |
80% | N/A | N/A | |||||||
Probability of new contract execution |
20%-90% | N/A | N/A | |||||||
Expected annual revenue range |
$3,080-$3,590 | N/A | N/A | |||||||
Risk free interest rate |
1.6% | N/A | N/A | |||||||
Long-lived assets to be disposed of |
||||||||||
Property and Equipment |
N/A | $ | | $ | 3,040 |
Assets and Liabilities Measured at Fair Value upon Initial Recognition
The carrying amount and the estimated fair value of financial instruments held by the Company as of September 30, 2015 were:
Carrying Amount |
Fair Value | |||||||
Cash and cash equivalents |
$ | 84,958 | $ | 84,958 | ||||
Accounts receivable |
$ | 278,826 | $ | 278,826 | ||||
Senior Credit Facilities (Level 1) |
$ | 1,779,008 | $ | 1,801,342 | ||||
Senior Notes (Level 2) |
$ | 978,205 | $ | 1,050,861 |
The carrying amounts of cash equivalents and accounts receivable approximate fair value because of their short-term maturities. The fair value of long-term debt is based upon market quotes and trades by investors in partial interests of these instruments.
9. Legal Proceedings
In the normal course of business, the Company is involved in various claims and legal proceedings. While the ultimate resolution of these matters has yet to be determined, the Company does not believe that their outcomes will have a material adverse effect on the Companys consolidated financial position, results of operations or liquidity.
20
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
10. Income Taxes
In May 2015, the state of Tennessee enacted the Tennessee Revenue Modernization Act, which changed the manner in which the Companys Tennessee apportionment is determined. This change in the Companys Tennessee apportionment, along with routine changes in apportionment that arose following the filing of the Companys annual tax returns, resulted in a change in the Companys effective state income tax rate.
Additionally, during the nine months ended September 30, 2015, the Company revised its estimates of its contingent consideration obligations related to two of its acquisitions.
After giving effect to the changes in the Companys Tennessee apportionment, changes in contingent consideration and other items, income taxes for the nine months ended September 30, 2015 amounted to an income tax benefit of $32,264 and an effective tax rate of 51.2%. The income tax benefit for the nine months ended September 30, 2014 was $43,733 and resulted in an effective tax rate of 36.7%.
11. Tax Receivable Agreement Obligation to Related Parties
The Company is a party to tax receivable agreements which obligate it to make payments to certain of its current and former owners, including affiliates of Blackstone, Hellman & Friedman and certain members of management (collectively, the TRA Members), equal to 85% of the applicable cash savings that the Company realizes as a result of tax attributes arising from certain previous transactions, including the Merger. The Company will retain the benefit of the remaining 15% of these tax savings. The Company expects cumulative remaining payments under the tax receivable agreements of approximately $353,048. $180,182 of this amount, which reflected the initial fair value of the tax receivable agreement obligations plus recognized accretion, was reflected as an obligation on the accompanying unaudited condensed consolidated balance sheet at September 30, 2015.
12. Segment Reporting
Management views the Companys operating results in three reportable segments: (a) software and analytics, (b) network solutions and (c) technology-enabled services. Listed below are the results of operations for each of the reportable segments. This information is reflected in the manner utilized by management to make operating decisions, assess performance and allocate resources. Such amounts include allocations of corporate shared services functions that are essential to the core operations of the reportable segments such as information technology, operations and product development functions. Segment assets and related depreciation expenses are not presented to management for purposes of operational decision making, and therefore are not included in the accompanying tables. The accounting policies of the operating segments are the same as those described in the summary of significant accounting policies in the notes to the Companys audited consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2014 as filed with the SEC.
Software and Analytics
The software and analytics segment provides revenue cycle technology, revenue optimization, payment integrity, electronic payment, risk adjustment, quality reporting, data and analytic and consumer engagement solutions.
Network Solutions
The network solutions segment provides financial and administrative information exchange solutions for medical, dental and pharmacy claims management and other standardized healthcare transactions, including clinical information exchange capabilities.
Technology-enabled Services
The technology-enabled services segment provides payment and communication, eligibility and enrollment, healthcare consulting, payment automation and pharmacy benefits administration solutions.
21
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
Corporate and Eliminations
Corporate and eliminations includes pass-through postage costs, management, administrative and certain other shared corporate services functions such as legal, finance, human resources and marketing, as well as eliminations to remove inter-segment revenue and expenses. Inter-segment revenue and expenses primarily represent claims management and payment and communication solutions provided between segments. These administrative costs are excluded from the adjusted EBITDA measure for each respective operating segment.
22
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
The revenue and adjusted EBITDA for the operating segments are as follows:
Three Months Ended September 30, 2015 | ||||||||||||||||||||
Software and Analytics |
Network Solutions |
Technology- enabled Services |
Corporate and Eliminations |
Consolidated | ||||||||||||||||
Revenue from external customers: |
||||||||||||||||||||
Solutions revenue |
$ | 97,458 | $ | 93,415 | $ | 103,784 | $ | (6,711 | ) | $ | 287,946 | |||||||||
Postage revenue |
| | | 89,839 | 89,839 | |||||||||||||||
Inter-segment revenue |
308 | 146 | 1,047 | (1,501 | ) | | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net revenue |
$ | 97,766 | $ | 93,561 | $ | 104,831 | $ | 81,627 | $ | 377,785 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income (loss) before income taxes |
37,280 | 49,914 | 35,224 | (165,602 | ) | (43,184 | ) | |||||||||||||
Interest expense |
| | | 45,541 | 45,541 | |||||||||||||||
Depreciation and amortization |
| | | 85,817 | 85,817 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
EBITDA |
37,280 | 49,914 | 35,224 | (34,244 | ) | 88,174 | ||||||||||||||
Equity compensation |
426 | 166 | 240 | 1,799 | 2,631 | |||||||||||||||
Acquisition accounting adjustments |
227 | 1 | 158 | | 386 | |||||||||||||||
Acquisition-related costs |
58 | 11 | 108 | 3,551 | 3,728 | |||||||||||||||
Transaction-related costs and advisory fees |
| | | 1,960 | 1,960 | |||||||||||||||
Strategic initiatives, duplicative and transition costs |
738 | 318 | 414 | 619 | 2,089 | |||||||||||||||
Severance costs |
429 | 178 | 371 | (131 | ) | 847 | ||||||||||||||
Accretion |
| | | 6,458 | 6,458 | |||||||||||||||
Impairment of long-lived assets |
| | | 219 | 219 | |||||||||||||||
Contingent consideration |
(4,660 | ) | | | | (4,660 | ) | |||||||||||||
Other non-routine, net |
392 | 462 | (272 | ) | (633 | ) | (51 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
EBITDA Adjustments |
(2,390 | ) | 1,136 | 1,019 | 13,842 | 13,607 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Adjusted EBITDA |
$ | 34,890 | $ | 51,050 | $ | 36,243 | $ | (20,402 | ) | $ | 101,781 | |||||||||
|
|
|
|
|
|
|
|
|
|
23
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
Three Months Ended September 30, 2014 | ||||||||||||||||||||
Software and Analytics |
Network Solutions |
Technology- enabled Services |
Corporate and Eliminations |
Consolidated | ||||||||||||||||
Revenue from external customers: |
||||||||||||||||||||
Solutions revenue |
$ | 61,884 | $ | 90,236 | $ | 109,094 | $ | (6,199 | ) | $ | 255,015 | |||||||||
Postage revenue |
| | | 86,593 | 86,593 | |||||||||||||||
Inter-segment revenue |
312 | 90 | 2,178 | (2,580 | ) | | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net revenue |
$ | 62,196 | $ | 90,326 | $ | 111,272 | $ | 77,814 | $ | 341,608 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income (loss) before income taxes |
21,955 | 44,659 | 38,789 | (113,912 | ) | (8,509 | ) | |||||||||||||
Interest expense |
| | | 36,635 | 36,635 | |||||||||||||||
Depreciation and amortization |
| | | 48,448 | 48,448 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
EBITDA |
21,955 | 44,659 | 38,789 | (28,829 | ) | 76,574 | ||||||||||||||
Equity compensation |
165 | 149 | 304 | 1,614 | 2,232 | |||||||||||||||
Acquisition accounting adjustments |
20 | (7 | ) | 176 | | 189 | ||||||||||||||
Acquisition-related costs |
16 | 25 | 11 | 1,336 | 1,388 | |||||||||||||||
Transaction-related costs and advisory fees |
| | | 1,683 | 1,683 | |||||||||||||||
Strategic initiatives, duplicative and transition costs |
16 | 15 | 11 | 364 | 406 | |||||||||||||||
Severance costs |
63 | 209 | 870 | 694 | 1,836 | |||||||||||||||
Accretion |
| | | 4,452 | 4,452 | |||||||||||||||
Impairment of long-lived assets |
| 19 | 165 | 2,930 | 3,114 | |||||||||||||||
Contingent consideration |
| 647 | 1,329 | | 1,976 | |||||||||||||||
Other non-routine, net |
150 | 808 | 399 | (1,157 | ) | 200 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
EBITDA Adjustments |
430 | 1,865 | 3,265 | 11,916 | 17,476 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Adjusted EBITDA |
$ | 22,385 | $ | 46,524 | $ | 42,054 | $ | (16,913 | ) | $ | 94,050 | |||||||||
|
|
|
|
|
|
|
|
|
|
24
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
Nine Months Ended September 30, 2015 | ||||||||||||||||||||
Software and Analytics |
Network Solutions |
Technology- enabled Services |
Corporate and Eliminations |
Consolidated | ||||||||||||||||
Revenue from external customers: |
||||||||||||||||||||
Solutions revenue |
$ | 230,374 | $ | 276,314 | $ | 322,953 | $ | (19,479 | ) | $ | 810,162 | |||||||||
Postage revenue |
| | | 268,119 | 268,119 | |||||||||||||||
Inter-segment revenue |
819 | 268 | 3,071 | (4,158 | ) | | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net revenue |
$ | 231,193 | $ | 276,582 | $ | 326,024 | $ | 244,482 | $ | 1,078,281 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income (loss) before income taxes |
78,289 | 143,459 | 112,241 | (396,981 | ) | (62,992 | ) | |||||||||||||
Interest expense |
| | | 121,685 | 121,685 | |||||||||||||||
Depreciation and amortization |
| | | 183,446 | 183,446 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
EBITDA |
78,289 | 143,459 | 112,241 | (91,850 | ) | 242,139 | ||||||||||||||
Equity compensation |
1,477 | 466 | 176 | 4,695 | 6,814 | |||||||||||||||
Acquisition accounting adjustments |
834 | 4 | 546 | | 1,384 | |||||||||||||||
Acquisition-related costs |
91 | 65 | 934 | 5,792 | 6,882 | |||||||||||||||
Transaction-related costs and advisory fees |
| | | 5,138 | 5,138 | |||||||||||||||
Strategic initiatives, duplicative and transition costs |
1,580 | 674 | 644 | 2,426 | 5,324 | |||||||||||||||
Severance costs |
132 | 436 | 3,211 | 1,185 | 4,964 | |||||||||||||||
Accretion |
| | | 15,254 | 15,254 | |||||||||||||||
Impairment of long-lived assets |
| | | 1,180 | 1,180 | |||||||||||||||
Contingent consideration |
(4,730 | ) | (95 | ) | | | (4,825 | ) | ||||||||||||
Other non-routine, net |
1,034 | 1,702 | 404 | (162 | ) | 2,978 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
EBITDA Adjustments |
418 | 3,252 | 5,915 | 35,508 | 45,093 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Adjusted EBITDA |
$ | 78,707 | $ | 146,711 | $ | 118,156 | $ | (56,342 | ) | $ | 287,232 | |||||||||
|
|
|
|
|
|
|
|
|
|
25
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
Nine Months Ended September 30, 2014 | ||||||||||||||||||||
Software and Analytics |
Network Solutions |
Technology- enabled Services |
Corporate and Eliminations |
Consolidated | ||||||||||||||||
Revenue from external customers: |
||||||||||||||||||||
Solutions revenue |
$ | 178,055 | $ | 257,345 | $ | 322,445 | $ | (17,619 | ) | $ | 740,226 | |||||||||
Postage revenue |
| | | 256,747 | 256,747 | |||||||||||||||
Inter-segment revenue |
1,072 | 271 | 5,990 | (7,333 | ) | | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net revenue |
$ | 179,127 | $ | 257,616 | $ | 328,435 | $ | 231,795 | $ | 996,973 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income (loss) before income taxes |
59,342 | 123,330 | 33,361 | (335,282 | ) | (119,249 | ) | |||||||||||||
Interest expense |
| | | 109,741 | 109,741 | |||||||||||||||
Depreciation and amortization |
| | | 141,541 | 141,541 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
EBITDA |
59,342 | 123,330 | 33,361 | (84,000 | ) | 132,033 | ||||||||||||||
Equity compensation |
481 | 446 | 865 | 4,122 | 5,914 | |||||||||||||||
Acquisition accounting adjustments |
96 | 4 | 621 | 4 | 725 | |||||||||||||||
Acquisition-related costs |
45 | 62 | 1,410 | 3,376 | 4,893 | |||||||||||||||
Transaction-related costs and advisory fees |
| | | 4,799 | 4,799 | |||||||||||||||
Strategic initiatives, duplicative and transition costs |
102 | 152 | 74 | 9,431 | 9,759 | |||||||||||||||
Severance costs |
1,207 | 567 | 1,754 | 2,028 | 5,556 | |||||||||||||||
Accretion |
| | | 9,220 | 9,220 | |||||||||||||||
Impairment of long-lived assets |
218 | 2,569 | 76,376 | 3,526 | 82,689 | |||||||||||||||
Contingent consideration |
| 1,305 | 2,341 | | 3,646 | |||||||||||||||
Other non-routine, net |
833 | 1,607 | 2,497 | (1,485 | ) | 3,452 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
EBITDA Adjustments |
2,982 | 6,712 | 85,938 | 35,021 | 130,653 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Adjusted EBITDA |
$ | 62,324 | $ | 130,042 | $ | 119,299 | $ | (48,979 | ) | $ | 262,686 | |||||||||
|
|
|
|
|
|
|
|
|
|
13. Accumulated Other Comprehensive Income (Loss)
The following is a summary of the accumulated other comprehensive income (loss) balances, net of taxes, as of and for the nine months ended September 30, 2015.
Foreign Currency Translation Adjustment |
Cash Flow Hedge |
Accumulated Other Comprehensive Income (Loss) |
||||||||||
Balance at January 1, 2015 |
$ | (483 | ) | $ | (1,472 | ) | $ | (1,955 | ) | |||
Change associated with foreign currency translation |
(531 | ) | | (531 | ) | |||||||
Change associated with current period hedging |
| 1,490 | 1,490 | |||||||||
Reclassification into earnings |
| (1,935 | ) | (1,935 | ) | |||||||
|
|
|
|
|
|
|||||||
Balance at September 30, 2015 |
$ | (1,014 | ) | $ | (1,917 | ) | $ | (2,931 | ) | |||
|
|
|
|
|
|
14. Supplemental Condensed Consolidating Financial Information
In lieu of providing separate annual and interim financial statements for each guarantor of the Senior Notes, Regulation S-X provides companies, if certain criteria are satisfied, with the option to instead provide condensed consolidating financial information for its issuers, guarantors and non-guarantors. In the case of the Company, the applicable criteria include the following: (i) the Senior Notes are fully and unconditionally guaranteed on a joint and several basis (subject to customary release provisions), (ii) each of the guarantors of the Senior Notes is a direct or indirect 100% owned subsidiary of the Company and (iii) any non-guarantors are considered minor as that term is defined in Regulation S-X. Because each of these criteria has been satisfied by the Company, condensed consolidating balance sheets as of September 30, 2015 and December 31, 2014, condensed consolidating statements of operations and comprehensive income (loss) for the three and nine months ended September 30, 2015 and 2014, respectively, and condensed consolidating statements of cash flows for the nine months ended September 30, 2015 and 2014, respectively, for the Company, segregating the issuer, the subsidiary guarantors and consolidating adjustments, are reflected below. Prior period amounts have been reclassified to conform to the current year presentation.
26
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
Condensed Consolidating Balance Sheet
As of September 30, 2015 | ||||||||||||||||
Emdeon Inc. | Guarantor Subsidiaries |
Consolidating Adjustments |
Consolidated | |||||||||||||
ASSETS |
||||||||||||||||
Current assets: |
||||||||||||||||
Cash and cash equivalents |
$ | 703 | $ | 84,255 | $ | | $ | 84,958 | ||||||||
Accounts receivable, net of allowance for doubtful accounts |
| 278,826 | | 278,826 | ||||||||||||
Deferred income tax assets |
| 15,457 | | 15,457 | ||||||||||||
Prepaid expenses and other current assets |
2,749 | 31,605 | | 34,354 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total current assets |
3,452 | 410,143 | | 413,595 | ||||||||||||
Property and equipment, net |
4 | 299,031 | | 299,035 | ||||||||||||
Due from affiliates |
167,339 | | (167,339 | ) | | |||||||||||
Investment in consolidated subsidiaries |
1,793,496 | | (1,793,496 | ) | | |||||||||||
Goodwill |
| 2,291,375 | | 2,291,375 | ||||||||||||
Intangible assets, net |
95,875 | 1,598,963 | | 1,694,838 | ||||||||||||
Other assets, net |
206,873 | 7,964 | (206,796 | ) | 8,041 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total assets |
$ | 2,267,039 | $ | 4,607,476 | $ | (2,167,631 | ) | $ | 4,706,884 | |||||||
|
|
|
|
|
|
|
|
|||||||||
LIABILITIES AND EQUITY |
||||||||||||||||
Current liabilities: |
||||||||||||||||
Accounts payable |
$ | | $ | 27,265 | $ | | $ | 27,265 | ||||||||
Accrued expenses |
18,056 | 191,048 | | 209,104 | ||||||||||||
Deferred revenues |
| 12,005 | | 12,005 | ||||||||||||
Current portion of long-term debt |
6,796 | 24,469 | | 31,265 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total current liabilities |
24,852 | 254,787 | | 279,639 | ||||||||||||
Due to affiliates |
| 167,339 | (167,339 | ) | | |||||||||||
Long-term debt, excluding current portion |
1,022,049 | 1,728,281 | | 2,750,330 | ||||||||||||
Deferred income tax liabilities |
| 655,725 | (206,796 | ) | 448,929 | |||||||||||
Tax receivable agreement obligations to related parties |
179,237 | | | 179,237 | ||||||||||||
Other long-term liabilities |
1,196 | 7,848 | | 9,044 | ||||||||||||
Commitments and contingencies |
||||||||||||||||
Equity |
1,039,705 | 1,793,496 | (1,793,496 | ) | 1,039,705 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total liabilities and equity |
$ | 2,267,039 | $ | 4,607,476 | $ | (2,167,631 | ) | $ | 4,706,884 | |||||||
|
|
|
|
|
|
|
|
27
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
Condensed Consolidating Balance Sheet
As of December 31, 2014 | ||||||||||||||||
Emdeon Inc. | Guarantor Subsidiaries |
Consolidating Adjustments |
Consolidated | |||||||||||||
ASSETS |
||||||||||||||||
Current assets: |
||||||||||||||||
Cash and cash equivalents |
$ | 796 | $ | 81,510 | $ | | $ | 82,306 | ||||||||
Accounts receivable, net of allowance for doubtful accounts |
| 233,791 | | 233,791 | ||||||||||||
Deferred income tax assets |
| 18,893 | | 18,893 | ||||||||||||
Prepaid expenses and other current assets |
2,267 | 26,979 | | 29,246 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total current assets |
3,063 | 361,173 | | 364,236 | ||||||||||||
Property and equipment, net |
7 | 244,146 | | 244,153 | ||||||||||||
Due from affiliates |
| 180,610 | (180,610 | ) | | |||||||||||
Investment in subsidiaries |
1,740,062 | | (1,740,062 | ) | | |||||||||||
Goodwill |
| 1,702,569 | | 1,702,569 | ||||||||||||
Intangible assets, net |
133,500 | 1,405,894 | | 1,539,394 | ||||||||||||
Other assets, net |
150,906 | 7,924 | (149,647 | ) | 9,183 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total assets |
$ | 2,027,538 | $ | 3,902,316 | $ | (2,070,319 | ) | $ | 3,859,535 | |||||||
|
|
|
|
|
|
|
|
|||||||||
LIABILITIES AND EQUITY |
||||||||||||||||
Current liabilities: |
||||||||||||||||
Accounts payable |
$ | | $ | 16,399 | $ | | $ | 16,399 | ||||||||
Accrued expenses |
4,935 | 170,271 | | 175,206 | ||||||||||||
Deferred revenues |
| 10,518 | | 10,518 | ||||||||||||
Current portion of long-term debt |
6,709 | 20,599 | | 27,308 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total current liabilities |
11,644 | 217,787 | | 229,431 | ||||||||||||
Due to affiliates |
180,610 | | (180,610 | ) | | |||||||||||
Long-term debt, excluding current portion |
769,236 | 1,366,232 | | 2,135,468 | ||||||||||||
Deferred income tax liabilities |
| 562,874 | (149,647 | ) | 413,227 | |||||||||||
Tax receivable agreement obligations to related parties |
163,983 | | | 163,983 | ||||||||||||
Other long-term liabilities |
| 15,361 | | 15,361 | ||||||||||||
Commitments and contingencies |
||||||||||||||||
Total equity |
902,065 | 1,740,062 | (1,740,062 | ) | 902,065 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total liabilities and equity |
$ | 2,027,538 | $ | 3,902,316 | $ | (2,070,319 | ) | $ | 3,859,535 | |||||||
|
|
|
|
|
|
|
|
28
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
Condensed Consolidating Statement of Operations
Three Months Ended September 30, 2015 | ||||||||||||||||
Emdeon Inc. | Guarantor Subsidiaries |
Consolidating Adjustments |
Consolidated | |||||||||||||
Revenue: |
||||||||||||||||
Solutions revenue |
$ | | $ | 287,946 | $ | | $ | 287,946 | ||||||||
Postage revenue |
| 89,839 | | 89,839 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total revenue |
| 377,785 | | 377,785 | ||||||||||||
Costs and expenses: |
||||||||||||||||
Cost of operations (exclusive of depreciation and amortization below) |
15 | 129,370 | | 129,385 | ||||||||||||
Development and engineering |
| 11,651 | | 11,651 | ||||||||||||
Sales, marketing, general and administrative |
1,974 | 54,745 | | 56,719 | ||||||||||||
Customer postage |
15 | 89,824 | | 89,839 | ||||||||||||
Depreciation and amortization |
33,133 | 52,684 | | 85,817 | ||||||||||||
Accretion |
6,458 | | | 6,458 | ||||||||||||
Impairment of long-lived assets |
| 219 | | 219 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating income (loss) |
(41,595 | ) | 39,292 | | (2,303 | ) | ||||||||||
Equity in earnings of consolidated subsidiaries |
(7,141 | ) | | 7,141 | | |||||||||||
Interest expense, net |
28,108 | 17,433 | | 45,541 | ||||||||||||
Contingent consideration |
| (4,660 | ) | | (4,660 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income (loss) before income tax provision (benefit) |
(62,562 | ) | 26,519 | (7,141 | ) | (43,184 | ) | |||||||||
Income tax provision (benefit) |
(29,656 | ) | 19,378 | | (10,278 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income (loss) |
$ | (32,906 | ) | $ | 7,141 | $ | (7,141 | ) | $ | (32,906 | ) | |||||
|
|
|
|
|
|
|
|
29
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
Condensed Consolidating Statement of Operations
Three Months Ended September 30, 2014 | ||||||||||||||||
Emdeon Inc. | Guarantor Subsidiaries |
Consolidating Adjustments |
Consolidated | |||||||||||||
Revenue: |
||||||||||||||||
Solutions revenue |
$ | | $ | 255,015 | $ | | $ | 255,015 | ||||||||
Postage revenue |
| 86,593 | | 86,593 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total revenue |
| 341,608 | | 341,608 | ||||||||||||
Costs and expenses: |
||||||||||||||||
Cost of operations (exclusive of depreciation and amortization below) |
| 116,909 | | 116,909 | ||||||||||||
Development and engineering |
| 8,117 | | 8,117 | ||||||||||||
Sales, marketing, general and administrative |
1,290 | 42,583 | | 43,873 | ||||||||||||
Customer postage |
| 86,593 | 86,593 | |||||||||||||
Depreciation and amortization |
2,251 | 46,197 | | 48,448 | ||||||||||||
Accretion |
4,452 | | | 4,452 | ||||||||||||
Impairment of long-lived assets |
| 3,114 | | 3,114 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating income (loss) |
(7,993 | ) | 38,095 | | 30,102 | |||||||||||
Equity in earnings of consolidated subsidiaries |
(10,110 | ) | | 10,110 | | |||||||||||
Interest expense, net |
23,418 | 13,217 | | 36,635 | ||||||||||||
Contingent consideration |
| 1,976 | | 1,976 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income (loss) before income tax provision (benefit) |
(21,301 | ) | 22,902 | (10,110 | ) | (8,509 | ) | |||||||||
Income tax provision (benefit) |
(8,299 | ) | 12,792 | | 4,493 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income (loss) |
$ | (13,002 | ) | $ | 10,110 | $ | (10,110 | ) | $ | (13,002 | ) | |||||
|
|
|
|
|
|
|
|
30
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
Condensed Consolidating Statement of Operations
Nine Months Ended September 30, 2015 | ||||||||||||||||
Emdeon Inc. | Guarantor Subsidiaries |
Consolidating Adjustments |
Consolidated | |||||||||||||
Revenue: |
||||||||||||||||
Solutions revenue |
$ | | $ | 810,162 | $ | | $ | 810,162 | ||||||||
Postage revenue |
| 268,119 | | 268,119 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total revenue |
| 1,078,281 | | 1,078,281 | ||||||||||||
Costs and expenses: |
||||||||||||||||
Cost of operations (exclusive of depreciation and amortization below) |
15 | 371,844 | | 371,859 | ||||||||||||
Development and engineering |
| 32,600 | | 32,600 | ||||||||||||
Sales, marketing, general and administrative |
7,828 | 144,127 | | 151,955 | ||||||||||||
Customer postage |
| 268,119 | | 268,119 | ||||||||||||
Depreciation and amortization |
37,633 | 145,813 | | 183,446 | ||||||||||||
Accretion |
15,254 | | | 15,254 | ||||||||||||
Impairment of long-lived assets |
| 1,180 | | 1,180 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating income (loss) |
(60,730 | ) | 114,598 | | 53,868 | |||||||||||
Equity in earnings of consolidated subsidiaries |
(47,865 | ) | | 47,865 | | |||||||||||
Interest expense, net |
74,697 | 46,988 | | 121,685 | ||||||||||||
Contingent consideration |
| (4,825 | ) | | (4,825 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income (loss) before income tax provision (benefit) |
(87,562 | ) | 72,435 | (47,865 | ) | (62,992 | ) | |||||||||
Income tax provision (benefit) |
(56,834 | ) | 24,570 | | (32,264 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income (loss) |
$ | (30,728 | ) | $ | 47,865 | $ | (47,865 | ) | $ | (30,728 | ) | |||||
|
|
|
|
|
|
|
|
31
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
Condensed Consolidating Statement of Operations
Nine Months Ended September 30, 2014 | ||||||||||||||||
Emdeon Inc. | Guarantor Subsidiaries |
Consolidating Adjustments |
Consolidated | |||||||||||||
Revenue |
||||||||||||||||
Solutions revenue |
$ | | $ | 740,226 | $ | | $ | 740,226 | ||||||||
Postage revenue |
| 256,747 | | 256,747 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total revenue |
| 996,973 | | 996,973 | ||||||||||||
Costs and expenses: |
||||||||||||||||
Cost of operations (exclusive of depreciation and amortization below) |
| 344,741 | | 344,741 | ||||||||||||
Development and engineering |
| 24,084 | | 24,084 | ||||||||||||
Sales, marketing, general and administrative |
13,775 | 134,006 | | 147,781 | ||||||||||||
Customer postage |
| 256,747 | | 256,747 | ||||||||||||
Depreciation and amortization |
6,753 | 134,788 | | 141,541 | ||||||||||||
Accretion |
9,220 | | | 9,220 | ||||||||||||
Impairment of long-lived assets |
| 82,689 | | 82,689 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating income (loss) |
(29,748 | ) | 19,918 | | (9,830 | ) | ||||||||||
Equity in earnings of consolidated subsidiaries |
51,018 | | (51,018 | ) | | |||||||||||
Interest expense, net |
70,224 | 39,517 | | 109,741 | ||||||||||||
Contingent consideration |
| 3,646 | | 3,646 | ||||||||||||
Other |
(111 | ) | (3,857 | ) | | (3,968 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Income (loss) before income tax provision (benefit) |
(150,879 | ) | (19,388 | ) | 51,018 | (119,249 | ) | |||||||||
Income tax provision (benefit) |
(75,363 | ) | 31,630 | | (43,733 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income (loss) |
$ | (75,516 | ) | $ | (51,018 | ) | $ | 51,018 | $ | (75,516 | ) | |||||
|
|
|
|
|
|
|
|
32
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
Condensed Consolidating Statement of Comprehensive Income (Loss)
Three Months Ended September 30, 2015 | ||||||||||||||||
Emdeon Inc. | Guarantor Subsidiaries |
Consolidating Adjustments |
Consolidated | |||||||||||||
Net income (loss) |
$ | (32,906 | ) | $ | 7,141 | $ | (7,141 | ) | $ | (32,906 | ) | |||||
Other comprehensive income (loss): |
||||||||||||||||
Changes in fair value of interest rate swap, net of taxes |
6 | | | 6 | ||||||||||||
Foreign currency translation adjustment |
| (347 | ) | | (347 | ) | ||||||||||
Equity in other comprehensive earnings |
(347 | ) | | 347 | | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Other comprehensive income (loss) |
(341 | ) | (347 | ) | 347 | (341 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Total comprehensive income (loss) |
$ | (33,247 | ) | $ | 6,794 | $ | (6,794 | ) | $ | (33,247 | ) | |||||
|
|
|
|
|
|
|
|
33
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
Condensed Consolidating Statement of Comprehensive Income (Loss)
Three Months Ended September 30, 2014 | ||||||||||||||||
Emdeon Inc. | Guarantor Subsidiaries |
Consolidating Adjustments |
Consolidated | |||||||||||||
Net income (loss) |
$ | (13,002 | ) | $ | 10,110 | $ | (10,110 | ) | $ | (13,002 | ) | |||||
Other comprehensive income (loss): |
||||||||||||||||
Changes in fair value of interest rate swap, net of taxes |
732 | | | 732 | ||||||||||||
Foreign currency translation adjustment |
| (127 | ) | | (127 | ) | ||||||||||
Equity in other comprehensive earnings |
(127 | ) | | 127 | | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Other comprehensive income (loss) |
605 | (127 | ) | 127 | 605 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total comprehensive income (loss) |
$ | (12,397 | ) | $ | 9,983 | $ | (9,983 | ) | $ | (12,397 | ) | |||||
|
|
|
|
|
|
|
|
34
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
Condensed Consolidating Statement of Comprehensive Income (Loss)
Nine Months Ended September 30, 2015 | ||||||||||||||||
Emdeon Inc. | Guarantor Subsidiaries |
Consolidating Adjustments |
Consolidated | |||||||||||||
Net income (loss) |
$ | (30,728 | ) | $ | 47,865 | $ | (47,865 | ) | $ | (30,728 | ) | |||||
Other comprehensive income (loss): |
||||||||||||||||
Changes in fair value of interest rate swap, net of taxes |
(445 | ) | | | (445 | ) | ||||||||||
Foreign currency translation adjustment |
| (531 | ) | | (531 | ) | ||||||||||
Equity in other comprehensive earnings |
(531 | ) | | 531 | | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Other comprehensive income (loss) |
(976 | ) | (531 | ) | 531 | (976 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Total comprehensive income (loss) |
$ | (31,704 | ) | $ | 47,334 | $ | (47,334 | ) | $ | (31,704 | ) | |||||
|
|
|
|
|
|
|
|
35
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
Condensed Consolidating Statement of Comprehensive Income (Loss)
Nine Months Ended September 30, 2014 | ||||||||||||||||
Emdeon Inc. | Guarantor Subsidiaries |
Consolidating Adjustments |
Consolidated | |||||||||||||
Net income (loss) |
$ | (75,516 | ) | $ | (51,018 | ) | $ | 51,018 | $ | (75,516 | ) | |||||
Other comprehensive income (loss): |
||||||||||||||||
Changes in fair value of interest rate swap, net of taxes |
(127 | ) | | | (127 | ) | ||||||||||
Foreign currency translation adjustment |
| (100 | ) | | (100 | ) | ||||||||||
Equity in other comprehensive earnings |
(100 | ) | | 100 | | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Other comprehensive income (loss) |
(227 | ) | (100 | ) | 100 | (227 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Total comprehensive income (loss) |
$ | (75,743 | ) | $ | (51,118 | ) | $ | 51,118 | $ | (75,743 | ) | |||||
|
|
|
|
|
|
|
|
36
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
Condensed Consolidating Statement of Cash Flows
Nine Months Ended September 30, 2015 | ||||||||||||||||
Emdeon Inc. | Guarantor Subsidiaries |
Consolidating Adjustments |
Consolidated | |||||||||||||
Operating activities |
||||||||||||||||
Net income (loss) |
$ | (30,728 | ) | $ | 47,865 | $ | (47,865 | ) | $ | (30,728 | ) | |||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
||||||||||||||||
Depreciation and amortization |
37,633 | 145,813 | | 183,446 | ||||||||||||
Accretion |
15,254 | | | 15,254 | ||||||||||||
Equity compensation |
229 | 6,585 | | 6,814 | ||||||||||||
Deferred income tax expense (benefit) |
(26,160 | ) | (2,677 | ) | | (28,837 | ) | |||||||||
Amortization of debt discount and issuance costs |
2,353 | 5,088 | | 7,441 | ||||||||||||
Contingent consideration |
| (4,825 | ) | | (4,825 | ) | ||||||||||
Impairment of long lived assets |
| 1,180 | | 1,180 | ||||||||||||
Equity in earnings of consolidated subsidiaries |
(47,865 | ) | | 47,865 | | |||||||||||
Other |
(1,488 | ) | 14 | | (1,474 | ) | ||||||||||
Changes in operating assets and liabilities: |
||||||||||||||||
Accounts receivable |
| 6,147 | | 6,147 | ||||||||||||
Prepaid expenses and other |
(30,546 | ) | 18,872 | | (11,674 | ) | ||||||||||
Accounts payable |
| 10,517 | | 10,517 | ||||||||||||
Accrued expenses, deferred revenue, and other liabilities |
16,627 | (17,545 | ) | | (918 | ) | ||||||||||
Due to/from affiliates |
(347,949 | ) | 347,949 | | | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net cash provided (used in) by operating activities |
(412,640 | ) | 564,983 | | 152,343 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Investing activities |
||||||||||||||||
Purchases of property and equipment |
| (39,175 | ) | | (39,175 | ) | ||||||||||
Payments for acquisitions, net of cash acquired |
| (717,669 | ) | | (717,669 | ) | ||||||||||
Other |
| (3,676 | ) | | (3,676 | ) | ||||||||||
Investment in subsidiary |
1,019 | | (1,019 | ) | | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net cash provided by (used in) investing activities |
1,019 | (760,520 | ) | (1,019 | ) | (760,520 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Financing activities |
||||||||||||||||
Distributions from (to) Emdeon Inc. net |
| (1,019 | ) | 1,019 | | |||||||||||
Proceeds from Term Loan Facility |
8,274 | 377,137 | | 385,411 | ||||||||||||
Proceeds from Senior Notes |
243,453 | | | 243,453 | ||||||||||||
Proceeds from Revolving Facility |
| 60,000 | | 60,000 | ||||||||||||
Payments on Revolving Facility |
| (60,000 | ) | | (60,000 | ) | ||||||||||
Payments on Term Loan Facility |
(229 | ) | (11,641 | ) | | (11,870 | ) | |||||||||
Payment of debt assumed from acquisition |
| (154,469 | ) | | (154,469 | ) | ||||||||||
Deferred financing obligation payments |
| (6,173 | ) | | (6,173 | ) | ||||||||||
Repurchase of Parent common stock |
(4,351 | ) | | | (4,351 | ) | ||||||||||
Capital contribution from Parent |
166,881 | | | 166,881 | ||||||||||||
Payment of contingent consideration |
| (5,553 | ) | | (5,553 | ) | ||||||||||
Other |
(2,500 | ) | | | (2,500 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net cash provided by (used in) financing activities |
411,528 | 198,282 | 1,019 | 610,829 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net decrease in cash and cash equivalents |
(93 | ) | 2,745 | | 2,652 | |||||||||||
Cash and cash equivalents at beginning of period |
796 | 81,510 | | 82,306 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Cash and cash equivalents at end of period |
$ | 703 | $ | 84,255 | $ | | $ | 84,958 | ||||||||
|
|
|
|
|
|
|
|
37
Emdeon Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited and amounts in thousands, except share and per share amounts)
Condensed Consolidating Statement of Cash Flows
Nine Months Ended September 30, 2014 | ||||||||||||||||
Emdeon Inc. | Guarantor Subsidiaries |
Consolidating Adjustments |
Consolidated | |||||||||||||
Operating activities |
||||||||||||||||
Net income (loss) |
$ | (75,516 | ) | $ | (51,018 | ) | $ | 51,018 | $ | (75,516 | ) | |||||
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: |
||||||||||||||||
Depreciation and amortization |
6,753 | 134,788 | | 141,541 | ||||||||||||
Accretion expense |
9,220 | | | 9,220 | ||||||||||||
Equity compensation expense |
255 | 5,659 | | 5,914 | ||||||||||||
Deferred income tax expense (benefit) |
(74,817 | ) | 29,931 | | (44,886 | ) | ||||||||||
Amortization of debt discount and issuance costs |
2,003 | 3,801 | | 5,804 | ||||||||||||
Contingent consideration |
| 3,646 | | 3,646 | ||||||||||||
Impairment of long lived assets |
| 82,689 | | 82,689 | ||||||||||||
Equity in earnings of consolidated subsidiaries |
51,018 | | (51,018 | ) | | |||||||||||
Other |
(1,094 | ) | (2,031 | ) | | (3,125 | ) | |||||||||
Changes in operating assets and liabilities: |
||||||||||||||||
Accounts receivable |
| (12,656 | ) | | (12,656 | ) | ||||||||||
Prepaid expenses and other |
(462 | ) | (4,028 | ) | | (4,490 | ) | |||||||||
Accounts payable |
| 644 | | 644 | ||||||||||||
Accrued expenses, deferred revenue, and other liabilities |
9,377 | (9,752 | ) | | (375 | ) | ||||||||||
Due to/from affiliates |
69,034 | (69,034 | ) | | | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net cash provided by (used in) operating activities |
(4,229 | ) | 112,639 | | 108,410 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Investing activities |
||||||||||||||||
Purchases of property and equipment |
| (37,673 | ) | | (37,673 | ) | ||||||||||
Payments for acquisitions, net of cash acquired |
| (87,909 | ) | | (87,909 | ) | ||||||||||
Other |
36 | (133 | ) | | (97 | ) | ||||||||||
Investment in subsidiaries, net |
50 | | (50 | ) | | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net cash provided by (used in) investing activities |
86 | (125,715 | ) | (50 | ) | (125,679 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Financing activities |
||||||||||||||||
Distributions from (to) Emdeon Inc., net |
| (50 | ) | 50 | | |||||||||||
Payments on Term Loan Facility |
(207 | ) | (9,452 | ) | | (9,659 | ) | |||||||||
Payment of debt assumed from acquisition |
| (23,262 | ) | | (23,262 | ) | ||||||||||
Proceeds from Revolving Facility |
| 65,000 | | 65,000 | ||||||||||||
Payments on Revolving Facility |
| (65,000 | ) | | (65,000 | ) | ||||||||||
Deferred financing obligation payments |
| (4,717 | ) | | (4,717 | ) | ||||||||||
Repurchase of Parent common stock |
(960 | ) | | | (960 | ) | ||||||||||
Capital contribution from Parent |
3,256 | | | 3,256 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net cash provided by (used in) financing activities |
2,089 | (37,481 | ) | 50 | (35,342 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in cash and cash equivalents |
(2,054 | ) | (50,557 | ) | | (52,611 | ) | |||||||||
Cash and cash equivalents at beginning of period |
2,794 | 73,744 | | 76,538 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Cash and cash equivalents at end of period |
$ | 740 | $ | 23,187 | $ | | $ | 23,927 | ||||||||
|
|
|
|
|
|
|
|
38
ITEM 2. | MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS |
The following discussion and analysis should be read in conjunction with the unaudited condensed consolidated financial statements and the accompanying notes in Part I, Item 1 of this Quarterly Report on Form 10-Q (Quarterly Report), together with the risk factors contained in the section titled Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2014 (Form 10-K) on file with the Securities and Exchange Commission (SEC) and elsewhere in the Quarterly Report.
Unless stated otherwise or the context otherwise requires, references in this Quarterly Report to we, us, our, Emdeon and the Company refer to Emdeon Inc. and its subsidiaries.
Forward-Looking Statements
This Quarterly Report includes certain forward-looking statements within the meaning of the federal securities laws regarding, among other things, our or our managements intentions, plans, beliefs, expectations or predictions of future events, which are considered forward-looking statements. You should not place undue reliance on those statements because they are subject to numerous uncertainties and factors relating to our operations and business environment, all of which are difficult to predict and many of which are beyond our control. Forward-looking statements include information concerning our possible or assumed future results of operations, including descriptions of our business strategy. These statements often include words such as may, will, should, believe, expect, anticipate, intend, plan, estimate or similar expressions. These statements are based upon assumptions that we have made in light of our experience in the industry, as well as our perceptions of historical trends, current conditions, expected future developments and other factors that we believe are appropriate under the circumstances. As you read this Quarterly Report, you should understand that these statements are not guarantees of performance or results. They involve known and unknown risks, uncertainties and assumptions, including those described under the heading Risk Factors in our Form 10-K and elsewhere in the Quarterly Report. Although we believe that these forward-looking statements are based upon reasonable assumptions, you should be aware that many factors, including those described under the heading Risk Factors in our Form 10-K and elsewhere in the Quarterly Report, could affect our actual financial results or results of operations and could cause actual results to differ materially from those in the forward-looking statements.
Our forward-looking statements made herein speak only as of the date on which made. We expressly disclaim any intent, obligation or undertaking to update or revise any forward-looking statements made herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements contained in this Quarterly Report.
Overview
We deliver our solutions and operate our business in three reportable segments: (i) software and analytics, which provides payment and reimbursement optimization and decision support solutions; (ii) network solutions, which leverages our health information network to optimize information exchange and workflows among healthcare system participants; and (iii) technology-enabled services, which provides payment and communication, workflow, advisory and other administrative solutions to optimize payment and reimbursement efficiencies. Through our software and analytics segment, we provide revenue cycle technology, revenue optimization, payment integrity, electronic payment, risk adjustment, quality reporting, data and analytic and consumer engagement solutions. Through our network solutions segment, we provide financial and administrative information exchange solutions for medical, dental and pharmacy claims management and other standardized healthcare transactions, including clinical information exchange capabilities. Through our technology-enabled services segment, we provide payment and communication, eligibility and enrollment, healthcare consulting, payment automation and pharmacy benefits administration solutions. We generally provide our solutions to payer, provider and pharmacy customers, including commercial insurance companies, third party administrators, governmental payers, self-insured employers, hospitals, physician practices, laboratories, pharmacies, pharmacy benefit management companies and government agencies.
There are a number of company-specific initiatives and industry trends that may affect our business volumes, revenues, cost of operations and margins. As part of our strategy, we encourage our customers to migrate from paper-based claim, communication, payment and other transaction processing to electronic, automated processing in order to improve efficiency. Our business is aligned with our customers to support this transition, and as they migrate from paper-based processing to electronic processing, even though our revenues for an applicable customer generally will decline, our margins and profitability will typically increase.
39
Part of our strategy also includes the development and introduction of new and updated solutions. Our new and updated solutions are likely to require us to incur development and engineering expenditures, both operating and capital, and related sales and marketing costs at increased levels in order to successfully develop and achieve market acceptance of such solutions. We also may acquire, or enter into agreements with third parties to assist us in providing, new solutions. For example, we offer our electronic payment solutions through banks or vendors who contract with banks and other financial service firms. The costs of these initiatives or the failure to achieve broad penetration in target markets with respect to new or updated solutions may negatively affect our results of operations, margins and cash flow. Because newly introduced solutions generally will have lower margins initially as compared to our existing and more mature solutions, our margins and margin growth may be adversely affected on a percentage basis until these new solutions achieve scale and maturity. In addition, we continue to improve the scalability and performance of our network and platform. Any improvements in our current network or platform, the development of new networks or platforms, including those leveraging cloud-based environments, may result in more operating costs and less capital expenditures as compared to prior periods.
In addition to our internal development efforts, we actively evaluate opportunities to improve and expand our solutions through strategic acquisitions. Our acquisition strategy focuses on identifying acquisitions that improve and streamline the business and administrative functions of healthcare. We believe our broad customer footprint allows us to deploy acquired solutions into our installed base, which, in turn, can help accelerate the growth of our acquired businesses. We also believe our management teams ability to identify acquisition opportunities that are complementary and synergistic to our business, and to integrate them into our existing operations with minimal disruption, will continue to play an important role in the expansion of our business and growth. Our success in acquiring and integrating acquired businesses into our existing operations, the associated costs of such acquisitions, including integration costs, and the operating characteristics of the acquired businesses also may impact our results of operations and margins. Because the businesses we acquire sometimes have lower margins than our existing businesses, primarily as a result of their lack of scale and maturity, our margins on a percentage basis may be adversely affected in the periods subsequent to an acquisition from revenue mix changes and integration activities associated with these acquisitions.
We also expect to continue to be affected by general economic, regulatory and demographic factors affecting the healthcare industry. Significant changes in regulatory schemes, such as the updated Health Insurance Portability and Accountability Act of 1996, American Recovery and Reinvestment Act of 2009, the Patient Protection and Affordable Care Act (ACA) and other federal healthcare policy initiatives, impact our customers healthcare activities. In particular, we believe the ACA has significantly affected the regulatory environment in which we and our customers operate by changing how healthcare services are covered, delivered and reimbursed through expanded coverage of uninsured individuals, reduced federal healthcare program spending, increased efforts to link federal healthcare program payments to quality and efficiency and insurance market reforms. Also, changes in federal and state reimbursement patterns and rates can impact the revenues in certain of our business lines, particularly our government program eligibility and enrollment solutions. Although we believe the ACA has resulted in an overall increase in healthcare utilization and volumes to date, we are unable to predict how providers, payers, pharmacies and other healthcare market participants will continue to respond to the various reform provisions of the ACA, and we cannot be sure that the markets for our solutions will continue to exist at current levels or that we will have adequate technical, financial and marketing resources to react to changes in those markets.
Demographic trends affecting the healthcare industry, such as population growth and aging or unemployment rates, also could affect the frequency and nature of our customers healthcare transactional activity. The impact of such changes could impact our revenues, cost of operations and infrastructure expenses and thereby affect our results of operations and the way we operate our business. For example, an increase in the United States population, if such increase is accompanied by an increase in the United States population that has health insurance benefits, or the aging of the United States population, which requires an overall increased need for healthcare services, may result in an increase in our business volumes which, in turn, may increase our revenues and cost of operations. Alternatively, a general economic downturn, which reduces the number of discretionary health procedures by patients, or a persistent high unemployment rate, which lessens healthcare utilization, may decrease or offset other growth in our volumes, which, in turn, may adversely impact our revenues and cost of operations.
Recent Developments
In January 2015, we reorganized our reportable segments as software and analytics, network solutions and technology-enabled services. This discussion and analysis related to prior periods has been restated to reflect our current organizational structure.
40
In January 2015, in order to clarify the nature of our customer related postage activities, we created separate captions on the statement of operations within revenue and costs and expenses, respectively.
In April 2015, we exercised our option to terminate all future obligations under the Vieosoft, Inc. (Vieosoft) stock purchase agreement in exchange for a future cash payment of approximately $4.7 million to the former stockholders of Vieosoft. This termination payment was not accepted and the former stockholders of Vieosoft have filed a lawsuit against us.
In August 2015, we acquired Altegra Health, Inc. (Altegra), a technology-enabled provider that assists payers and risk bearing providers with analytics and reporting capabilities for risk adjustment, member engagement and quality analysis to achieve actionable insights and improved management for value-based healthcare, for initial cash consideration and the assumption of certain liabilities.
In September 2015, we announced our plan to rebrand as Change HealthcareTM beginning in the fourth quarter of 2015. As a result of this plan, we revised the remaining useful life of our existing tradename asset. During the three months ended September 30, 2015, we recognized amortization expense of $31.5 million related to our existing tradename asset and expect to recognize $94.6 million of amortization related to our existing tradename asset during the three months ended December 31, 2015.
Our Revenues and Expenses
We generate virtually all of our revenue by using technology solutions to provide our customers services that automate and simplify business and administrative functions for payers, providers and pharmacies generally on either a per transaction, per document, per communication, per member per month, monthly flat-fee, contingent fee or hourly basis.
Cost of operations consists primarily of costs related to services we provide to customers and costs associated with the operation and maintenance of our networks. These costs primarily include materials costs related to our payment and communication solutions, rebates paid to our channel partners (net of rebates to certain customers that offset revenue) and data communications costs, all of which generally vary with our revenues and/or volumes. Cost of operations also includes personnel costs associated with production, network operations, customer support and other personnel, facilities expenses and equipment maintenance, all of which vary less directly with our revenue and/or volumes due to the fixed or semi-fixed nature of these expenses.
Rebates are paid to channel partners for electronic and other volumes delivered through our network to certain payers and can be impacted by the number of comprehensive management services agreements we execute with payers, the associated rate structure with our payer customers, the success of our direct sales efforts to providers and the extent to which direct connections to payers are developed by our channel partners. While these rebates are generally a component of our cost of operations, in cases where the channel partners are also our customers, these rebates generally are recognized as an offset to revenue.
Our data communication expense consists of telecommunication and transaction processing charges.
Our material costs relate primarily to our payment and communication solutions volumes, and consist primarily of paper and printing costs.
Development and engineering expense consists primarily of personnel costs related to the development, management and maintenance of our current and future solutions. We may invest more in this area in the future as we develop new and enhance existing solutions.
Sales, marketing, general and administrative expense consists primarily of personnel costs associated with our sales, account management and marketing functions, as well as management, administrative and other shared corporate services related to the operations of our operating segments and overall business operations.
Our development and engineering expense, sales, marketing, general and administrative expense and corporate expense, while related to our current operations, also are affected and influenced by our future plans including the development of new solutions, business strategies and enhancement and maintenance of our infrastructure.
Postage, which is generally billed as a pass-through cost to our customers, is the most significant cost incurred in the delivery of our payment and communication solutions. Our postage costs and related revenues increase as our payment and communication solutions volumes increase and also when the United States Postal Service (USPS) increases postage rates. Although the USPS historically has increased postage rates annually in most recent years, including in January 2014 and May 2015, the frequency and nature of such annual increases may not occur as regularly in the future.
41
Our depreciation and amortization expense is related to depreciation of our property and equipment, including technology assets, and amortization of intangible assets. The amount of depreciation and amortization expense is affected by the level of our recent investment in property and equipment, acquisition activity and asset impairments or certain changes in estimates.
Our interest expense consists principally of cash interest associated with our long-term debt obligations and non-cash interest associated with the amortization of borrowing costs and discounts related to debt issuance. If market interest rates on the variable portion of our long-term debt increase in the future, our interest expense may increase.
Our income taxes consist of federal and state income taxes. These amounts include current income taxes payable, as well as income taxes for which the payment is deferred to future periods and dependent on the occurrence of future events. Our income taxes are affected by the recognition of valuation allowances, our tax status and other items. For additional information, see the discussion of income taxes in the section Significant Items Affecting Comparability-Income Taxes.
Significant Items Affecting Comparability
Certain significant items or events should be considered to better understand differences in our results of operations from period to period. We believe that the following items or events have had a significant impact on our results of operations for the periods discussed below or may have a significant impact on our results of operations in future periods:
Acquisitions and Divestitures
We actively evaluate opportunities to improve and expand our business through targeted acquisitions that are consistent with our strategy. On occasion, we also may dispose of certain components of our business that no longer fit within our overall strategy. Because of our acquisition activity, our results of operations may not be directly comparable among periods. The following summarizes our acquisition transactions since January 1, 2014 and affected segments:
Date |
Business |
Description |
Affected Segment | |||
July 2014 |
Capario, Corp. (Capario) |
Technology-enabled provider of revenue cycle management solutions | Software and Analytics; Network Solutions | |||
November 2014 |
Change Healthcare Corporation (Change) |
Technology-enabled provider of healthcare consumer engagement solutions | Software and Analytics | |||
December 2014 |
Adminisource Communications, Inc. (Adminisource) | Technology-enabled provider of payment and communication solutions | Technology- enabled Services | |||
August 2015 |
Altegra | Technology-enabled provider of analytical and reporting solutions for risk adjustment, member engagement and quality analysis | Software and Analytics; Technology- enabled Services |
For certain of our acquisitions, we agreed to transfer additional consideration to the sellers of the acquired businesses in the event that specified performance measures are achieved. United States generally accepted accounting principles generally require us to recognize the initial fair value of the expected amount to be paid under such contingent consideration arrangements as a component of the total consideration transferred. Subsequent changes in the fair value of the amounts expected to be paid, however, are generally required to be recognized as a component of net income. Such changes in fair value may occur based on changes in the expected timing or amount of payments or the effect of discounting the liability for the time value of money.
Efficiency Measures
We evaluate and implement efficiency measures and other cost savings initiatives on an ongoing basis to improve our financial and operating performance through reorganization, cost savings, productivity improvements, product development
42
and other process improvements. For instance, we continue to evaluate measures to consolidate our data centers, operations and networks, to outsource certain information technology and operations functions and to streamline product development. The implementation of these measures often involves upfront cash costs related to severance, professional fees, contractor costs and/or capital expenditures, with the cost savings or other improvements not realized until the measures are successfully completed. Additionally, we may recognize impairment charges as a result of such initiatives.
Income Taxes
Our blended statutory federal and state income tax rates range from 37% to 42%. The following table and subsequent commentary reconciles our federal statutory rate to our effective income tax rate and describes the more significant reconciling factors:
Nine Months Ended | ||||||||
September 30, | ||||||||
2015 | 2014 | |||||||
Statutory United States federal tax rate |
35.0 | % | 35.0 | % | ||||
State income taxes (net of federal benefit) |
14.4 | 2.4 | ||||||
Contingent consideration |
2.7 | (1.1 | ) | |||||
Other |
(0.9 | ) | 0.4 | |||||
|
|
|
|
|||||
Effective income tax rate |
51.2 | % | 36.7 | % | ||||
|
|
|
|
State Income TaxesOur effective tax rate for state income taxes is generally impacted by changes in our apportionment. In May 2015, the state of Tennessee enacted the Tennessee Revenue Modernization Act. This legislation impacted our Tennessee apportionment which, in turn, resulted in a state tax benefit for the nine months ended September 30, 2015. In addition, our effective tax rate for state income taxes for the nine months ended September 30, 2014 was affected by the change in tax status of EBS Master LLC from a partnership to a corporation in January 2014.
Contingent ConsiderationWe recognize income or expense each period for changes in the fair value of our contingent consideration obligations for which we are not permitted to recognize corresponding taxable income or deduction (i.e. a permanent item). During the nine months ended September 30, 2015, we revised our estimates of our contingent consideration obligations related to two of our acquisitions.
Amendments to the Senior Credit Agreement and New Senior Notes
In December 2014 and August 2015, we borrowed an additional $160.0 million and $395.0 million, respectively, under incremental term loan facilities through amendments to our credit agreement (the Senior Credit Agreement) governing our senior secured term loan facility (the Term Loan Facility) and senior secured revolving credit facility (the Revolving Facility) (collectively, the Senior Credit Facilities).
In August 2015, we borrowed $250.0 million by issuing new 6% senior notes due 2021 (the 2021 Notes).
Critical Accounting Estimates
The preparation of financial statements in accordance with United States generally accepted accounting principles requires us to make estimates and assumptions that affect reported amounts and related disclosures. We consider an accounting estimate to be critical if:
| it requires assumptions to be made that were uncertain at the time the estimate was made; and |
| changes in the estimate or different estimates that could have been made could have a material impact on our consolidated results of operations and financial condition. |
We believe the current assumptions and other considerations used to estimate amounts reflected in our unaudited condensed consolidated financial statements are appropriate. However, if actual experience differs from the assumptions and other considerations used in estimating amounts reflected in our unaudited condensed consolidated financial statements, the resulting changes could have a material adverse effect on our unaudited condensed consolidated results of operations and financial condition.
43
In September 2015, we announced our plan to rebrand as Change Healthcare beginning in the fourth quarter of 2015. As a result of this plan, we revised the remaining useful life of our existing tradename asset. During the three months ended September 30, 2015, we recognized amortization expense of $31.5 million related to our existing tradename asset and expect to recognize $94.6 million of amortization related to our existing tradename asset during the three months ended December 31, 2015.
Except for the announcement of our plan to rebrand as Change Healthcare, we believe there have been no significant changes during the nine months ended September 30, 2015 to the items we disclosed as our critical accounting estimates in Managements Discussion and Analysis of Financial Condition and Results of Operations in our Form 10-K.
Results of Operations
The following table summarizes our consolidated results of operations for the three and nine months ended September 30, 2015 and 2014, respectively (amounts in thousands):
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||||||||
September 30, 2015 | September 30, 2014 | September 30, 2015 | September 30, 2014 | |||||||||||||||||||||||||||||
Amount | %
of Revenue(1) |
Amount | %
of Revenue(1) |
Amount | %
of Revenue(1) |
Amount | % of Revenue(1) |
|||||||||||||||||||||||||
Revenue: |
||||||||||||||||||||||||||||||||
Solutions revenue |
$ | 287,946 | 76.2 | % | $ | 255,015 | 74.7 | % | $ | 810,162 | 75.1 | % | $ | 740,226 | 74.2 | % | ||||||||||||||||
Postage revenue |
89,839 | 23.8 | 86,593 | 25.3 | 268,119 | 24.9 | 256,747 | 25.8 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total revenue |
377,785 | 100.0 | 341,608 | 100.0 | 1,078,281 | 100.0 | 996,973 | 100.0 | ||||||||||||||||||||||||
Cost and expenses: |
||||||||||||||||||||||||||||||||
Cost of operations (exclusive of depreciation and amortization below) |
129,385 | 44.9 | 116,909 | 45.8 | 371,859 | 45.9 | 344,741 | 46.6 | ||||||||||||||||||||||||
Development and engineering |
11,651 | 4.0 | 8,117 | 3.2 | 32,600 | 4.0 | 24,084 | 3.3 | ||||||||||||||||||||||||
Sales, marketing, general and administrative |
56,719 | 19.7 | 43,873 | 17.2 | 151,955 | 18.8 | 147,781 | 20.0 | ||||||||||||||||||||||||
Customer postage |
89,839 | 23.8 | 86,593 | 25.3 | 268,119 | 24.9 | 256,747 | 25.8 | ||||||||||||||||||||||||
Depreciation and amortization |
85,817 | 22.7 | 48,448 | 14.2 | 183,446 | 17.0 | 141,541 | 14.2 | ||||||||||||||||||||||||
Accretion |
6,458 | 1.7 | 4,452 | 1.3 | 15,254 | 1.4 | 9,220 | 0.9 | ||||||||||||||||||||||||
Impairment of long-lived assets |
219 | 0.1 | 3,114 | 0.9 | 1,180 | 0.1 | 82,689 | 8.3 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Operating income |
(2,303 | ) | (0.6 | ) | 30,102 | 8.8 | 53,868 | 5.0 | (9,830 | ) | (1.0 | ) | ||||||||||||||||||||
Interest expense, net |
45,541 | 12.1 | 36,635 | 10.7 | 121,685 | 11.3 | 109,741 | 11.0 | ||||||||||||||||||||||||
Contingent consideration |
(4,660 | ) | (1.2 | ) | 1,976 | 0.6 | (4,825 | ) | (0.4 | ) | 3,646 | 0.4 | ||||||||||||||||||||
Other |
| | | | | | (3,968 | ) | (0.4 | ) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Income (loss) before income tax provision (benefit) |
(43,184 | ) | (11.4 | ) | (8,509 | ) | (2.5 | ) | (62,992 | ) | (5.8 | ) | (119,249 | ) | (12.0 | ) | ||||||||||||||||
Income tax provision (benefit) |
(10,278 | ) | (2.7 | ) | 4,493 | 1.3 | (32,264 | ) | (3.0 | ) | (43,733 | ) | (4.4 | ) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Net income (loss) |
$ | (32,906 | ) | (8.7 | )% | $ | (13,002 | ) | (3.8 | )% | $ | (30,728 | ) | (2.8 | )% | $ | (75,516 | ) | (7.6 | )% | ||||||||||||
|
|
|
|
|
|
|
|
(1) | Percentages of revenue for cost of operations, development and engineering and sales, marketing, general and administrative line items are based on solutions revenue. |
Three Months Ended September 30, 2015 Compared to Three Months Ended September 30, 2014
Solutions Revenues
Our solutions revenues were $287.9 million for the three months ended September 30, 2015 as compared to $255.0 million for the three months ended September 30, 2014, an increase of $32.9 million, or 12.9%. Factors affecting our solutions revenues are described in the various segment discussions below.
Cost of Operations
Our total cost of operations was $129.4 million for the three months ended September 30, 2015 as compared to $116.9 million for the three months ended September 30, 2014, an increase of $12.5 million, or 10.7%. The increase in our cost of operations is primarily due to volume growth and the impact of acquired businesses. As a percentage of solutions revenue, our cost of operations was 44.9% for the three months ended September 30, 2015 as compared to 45.8% for the three months ended September 30, 2014. The decrease in our cost of operations as a percentage of revenue is primarily due to changes in revenue mix and increased productivity.
44
Development and Engineering Expense
Our total development and engineering expense was $11.7 million for the three months ended September 30, 2015 as compared to $8.1 million for the three months ended September 30, 2014, an increase of $3.5 million, or 43.5%. The increase in our development and engineering expense is primarily due to the impact of acquired businesses and continued enhancements and development of existing and new solutions.
Sales, Marketing, General and Administrative Expense
Our total sales, marketing, general and administrative expense was $56.7 million for the three months ended September 30, 2015 as compared to $43.9 million for the three months ended September 30, 2014, an increase of $12.8 million, or 29.3%. The increase in our sales, marketing, general and administrative expense was primarily due to business growth, including the impact of acquired businesses and increased strategic initiatives, partially offset by productivity improvements and efficiency measures.
Postage
Our postage revenue and customer postage expense was $89.8 million for the three months ended September 30, 2015 as compared to $86.6 million for the three months ended September 30, 2014, an increase of $3.2 million, or 3.7%. This increase in postage revenue and corresponding expense was due to the impact of acquired businesses and the United States postage rate increase effective in May 2015, partially offset by customer attrition.
Depreciation and Amortization Expense
Our depreciation and amortization expense was $85.8 million for the three months ended September 30, 2015 as compared to $48.4 million for the three months ended September 30, 2014, an increase of $37.4 million, or 77.1%. This increase was primarily due to the acceleration of amortization of our existing tradename as a result of our plan to rebrand to Change Healthcare and the impact of acquired businesses.
Accretion
Our accretion expense was $6.5 million for the three months ended September 30, 2015 as compared to $4.5 million for the three months ended September 30, 2014. The amount recognized as accretion can vary significantly from period to period due to changes in estimates related to the amount or timing of our tax receivable agreement obligation payments. Such changes can result from a variety of factors, including changes in tax rates and the expected timing of prior net operating loss utilization, which can be affected by business combinations, changes in corporate structure, leverage, operations or other factors.
Interest Expense
Our interest expense was $45.5 million for the three months ended September 30, 2015 as compared to $36.6 million for the three months ended September 30, 2014, an increase of $8.9 million, or 24.3%. This increase was primarily due to the impact of the December 2014 and August 2015 incremental term loans and the 2021 Notes, partially offset by scheduled principal payments of term loans under the Senior Credit Facilities.
Income Taxes
Our income tax benefit was $10.3 million for the three months ended September 30, 2015 as compared to an income tax provision of $4.5 million for the three months ended September 30, 2014. Our effective tax rate was 23.8% for the three months ended September 30, 2015 as compared to 52.8% for the three months ended September 30, 2014. The effective tax rate for the three months ended September 30, 2015 was affected by changes in state tax apportionment, statutory rates, valuation allowance and other permanent items.
Segment Revenues and Adjusted EBITDA
We operate our business in three reportable segments: software and analytics, network solutions and technology-enabled services. We also maintain a corporate function which includes pass-through postage costs, management, administrative and certain other shared corporate services functions such as legal, finance, human resources and marketing, as well as eliminations to remove inter-segment revenue and expenses.
45
The segment profit measure primarily utilized by management is adjusted EBITDA which is defined as EBITDA (defined as net income (loss) before net interest expense, income tax provision (benefit) and depreciation and amortization), plus certain other non-cash or non-operating items. The non-cash or other non-operating items affecting the segment profit measure generally include equity compensation; acquisition accounting adjustments; acquisition-related costs; strategic initiatives, duplicative and transition costs; impairment of long lived assets; and contingent consideration adjustments. Adjusted EBITDA for the respective segments excludes all costs and adjustments associated with the above-referenced corporate functions. Financial information, including details of our adjustments to EBITDA, for each of our segments is set forth in Note 12 to the unaudited condensed consolidated financial statements included in Item 1 of this Quarterly Report.
Software and Analytics
Our software and analytics segment revenue and adjusted EBITDA is summarized in the following table (in thousands):
September 30, 2015 |
September 30, 2014 |
$ Change | ||||||||||
Solutions revenue |
$ | 97,458 | $ | 61,884 | $ | 35,574 | ||||||
Adjusted EBITDA |
$ | 34,890 | $ | 22,385 | $ | 12,505 |
Software and analytics revenue for the three months ended September 30, 2015 increased by $35.6 million, or 57.5%, as compared to the prior year period. This increase was primarily driven by acquired businesses, including $26.7 million related to the Altegra acquisition, and new sales and implementations.
Software and analytics adjusted EBITDA for the three months ended September 30, 2015 increased by $12.5 million, or 55.9% as compared to the prior year period. The increase in our software and analytics adjusted EBITDA is primarily due to the impact of the revenue items described above, partially offset by increased strategic growth initiative costs. As a percentage of solutions revenue, software and analytics adjusted EBITDA was 35.8% for the three months ended September 30, 2015 as compared to 36.2% for the three months ended September 30, 2014. The decrease in our software and analytics adjusted EBITDA as a percentage of solutions revenue is primarily due to the impact of the Altegra acquisition and increased strategic investments in consumer engagement and electronic payment solutions.
Network Solutions
Our network solutions segment revenue and adjusted EBITDA is summarized in the following table (in thousands):
September 30, 2015 |
September 30, 2014 |
$ Change | ||||||||||
Solutions revenue |
$ | 93,415 | $ | 90,236 | $ | 3,179 | ||||||
Adjusted EBITDA |
$ | 51,050 | $ | 46,524 | $ | 4,526 |
Network solutions revenue for the three months ended September 30, 2015 increased by $3.2 million, or 3.5%, as compared to the prior year period primarily due to increased volumes and new sales and implementations, partially offset by customer attrition.
Network solutions adjusted EBITDA for the three months ended September 30, 2015 increased by $4.5 million, or 9.7%, as compared to the prior year period. As a percentage of solutions revenue, network solutions adjusted EBITDA was 54.6% for the three months ended September 30, 2015 as compared to 51.6% for the three months ended September 30, 2014. The increase in network solutions adjusted EBITDA and as a percentage of solutions revenue was primarily due to the impact of the revenue items described above, pricing initiatives and other efficiency measures.
46
Technology-enabled Services
Our technology-enabled services segment revenue and adjusted EBITDA is summarized in the following table (in thousands):
September 30, 2015 |
September 30, 2014 |
$ Change | ||||||||||
Solutions revenue |
$ | 103,784 | $ | 109,094 | $ | (5,310 | ) | |||||
Adjusted EBITDA |
$ | 36,243 | $ | 42,054 | $ | (5,811 | ) |
Technology-enabled services revenue for the three months ended September 30, 2015 decreased by $5.3 million, or 4.9%, as compared to the prior year period. This decrease was primarily due to customer attrition, including the previously disclosed partial loss of a customer contract in the second quarter of 2014, the effects of changing reimbursement patterns and rates of federal and state payers related to our government program eligibility and enrollment services and decreased volumes in our payment and communication solutions, partially offset by the impact of acquired businesses and new sales and implementations.
Technology-enabled services adjusted EBITDA for the three months ended September 30, 2015 decreased by $5.8 million, or 13.8%, as compared to the prior year period. As a percentage of solutions revenue, technology-enabled services adjusted EBITDA was 34.9% for the three months ended September 30, 2015 as compared to 38.5% for the prior year period. The decrease in technology-enabled services adjusted EBITDA and as a percentage of solutions revenue was primarily due to the impact of the revenue items described above and changes in revenue mix, partially offset by productivity improvements and other efficiency measures.
Nine months Ended September 30, 2015 Compared to Nine months Ended September 30, 2014
Solutions Revenues
Our solutions revenues were $810.2 million for the nine months ended September 30, 2015 as compared to $740.2 million for the nine months ended September 30, 2014, an increase of $69.9 million, or 9.4%. Factors affecting our solutions revenues are described in the various segment discussions below.
Cost of Operations
Our total cost of operations was $371.9 million for the nine months ended September 30, 2015 as compared to $344.7 million for the nine months ended September 30, 2014, an increase of $27.1 million, or 7.9%. The increase in our cost of operations is primarily due to volume growth and the impact of acquired businesses. As a percentage of solutions revenue, our cost of operations was 45.9% for the nine months ended September 30, 2015 as compared to 46.6% for the nine months ended September 30, 2014. The decrease in our cost of operations as a percentage of revenue is primarily due to changes in revenue mix and increased productivity.
Development and Engineering Expense
Our total development and engineering expense was $32.6 million for the nine months ended September 30, 2015 as compared to $24.1 million for the nine months ended September 30, 2014, an increase of $8.5 million, or 35.4%. The increase in our development and engineering expense is primarily due to increased research and development and the impact of acquired businesses.
Sales, Marketing, General and Administrative Expense
Our total sales, marketing, general and administrative expense was $152.0 million for the nine months ended September 30, 2015 as compared to $147.8 million for the nine months ended September 30, 2014, an increase of $4.2 million, or 2.8%. The increase in our sales, marketing, general and administrative expense was primarily due to business growth, including the impact of acquired businesses and increased strategic initiatives, partially offset by productivity improvements and efficiency measures.
47
Postage
Our postage revenue and customer postage expense was $268.1 million for the nine months ended September 30, 2015 as compared to $256.7 million for the nine months ended September 30, 2014, an increase of $11.4 million, or 4.4%. This increase in postage revenue and corresponding expense was due to the impact of acquired businesses and the United States postage rate increase effective in May 2015, partially offset by customer attrition.
Depreciation and Amortization Expense
Our depreciation and amortization expense was $183.4 million for the nine months ended September 30, 2015 as compared to $141.5 million for the nine months ended September 30, 2014, an increase of $41.9 million, or 29.6%. This increase was primarily due to the acceleration of amortization of our existing tradename as a result of our plan to rebrand as Change Healthcare and the impact of acquired businesses.
Accretion
Our accretion expense was $15.3 million for the nine months ended September 30, 2015 as compared to $9.2 million for the nine months ended September 30, 2014. The amount recognized as accretion can vary significantly from period to period due to changes in estimates related to the amount or timing of our tax receivable agreement obligation payments. Such changes can result from a variety of factors, including changes in tax rates and the expected timing of prior net operating loss utilization, which can be affected by business combinations, changes in corporate structure, leverage, operations or other factors.
Interest Expense
Our interest expense was $121.7 million for the nine months ended September 30, 2015 as compared to $109.7 million for the nine months ended September 30, 2014, an increase of $11.9 million, or 10.9%. This increase was primarily due to the impact of the December 2014 and August 2015 incremental term loans and the 2021 Notes, partially offset by scheduled principal payments of term loans under the Senior Credit Facilities.
Income Taxes
Our income tax benefit was $32.3 million for the nine months ended September 30, 2015 as compared to $43.7 million for the nine months ended September 30, 2014. Our effective tax rate was 51.2% for the nine months ended September 30, 2015 as compared to 36.7% for the nine months ended September 30, 2014. The effective tax rate for the nine months ended September 30, 2015 was affected by changes in state tax apportionment, statutory rates, valuation allowance and other permanent items.
Segment Revenues and Adjusted EBITDA
Software and Analytics
Our software and analytics segment revenue and adjusted EBITDA is summarized in the following table (in thousands):
September 30, 2015 |
September 30, 2014 |
$ Change | ||||||||||
Solutions Revenue |
$ | 230,374 | $ | 178,055 | $ | 52,319 | ||||||
Adjusted EBITDA |
$ | 78,707 | $ | 62,324 | $ | 16,383 |
Software and analytics revenue for the nine months ended September 30, 2015 increased by $52.3 million, or 29.4%, as compared to the prior year period. This increase was primarily driven by acquired businesses, including $26.7 million related to the Altegra acquisition, and new sales and implementations.
Software and analytics adjusted EBITDA for the nine months ended September 30, 2015 increased by $16.4 million, or 26.3%, as compared to the prior year period. The increase in our software and analytics adjusted EBITDA is primarily due to the impact of the revenue items described above, partially offset by increased strategic growth initiative costs. As a percentage of solutions revenue, software and analytics adjusted EBITDA was 34.2% for the nine months ended September
48
30, 2015 as compared to 35.0% for the nine months ended September 30, 2014. The decrease in our software and analytics adjusted EBITDA as a percentage of solutions revenue is primarily due to the impact of the Altegra acquisition and increased strategic investments in consumer engagement and electronic payment solutions.
Network Solutions
Our network solutions segment revenue and adjusted EBITDA is summarized in the following table (in thousands):
September 30, 2015 |
September 30, 2014 |
$ Change | ||||||||||
Solutions Revenue |
$ | 276,314 | $ | 257,345 | $ | 18,969 | ||||||
Adjusted EBITDA |
$ | 146,711 | $ | 130,042 | $ | 16,669 |
Network solutions revenue for the nine months ended September 30, 2015 increased by $19.0 million, or 7.4%, as compared to the prior year period primarily due to increased volumes, new sales and implementations and the impact of acquired businesses, partially offset by customer attrition.
Network solutions adjusted EBITDA for the nine months ended September 30, 2015 increased by $16.7 million, or 12.8%, as compared to the prior year period. As a percentage of solutions revenue, network solutions adjusted EBITDA was 53.1% for the nine months ended September 30, 2015 as compared to 50.5% for the nine months ended September 30, 2014. The increase in network solutions adjusted EBITDA and as a percentage of solutions revenue was primarily due to the impact of the revenue items described above, pricing initiatives and other efficiency measures.
Technology-enabled Services
Our technology-enabled services segment revenue and adjusted EBITDA is summarized in the following table (in thousands):
September 30, 2015 |
September 30, 2014 |
$ Change | ||||||||||
Solutions Revenue |
$ | 322,953 | $ | 322,445 | $ | 508 | ||||||
Adjusted EBITDA |
$ | 118,156 | $ | 119,299 | $ | (1,143 | ) |
Technology-enabled services revenue for the nine months ended September 30, 2015 increased by $0.5 million, or 0.2%, as compared to the prior year period. This increase was primarily due to the impact of acquired businesses, partially offset by customer attrition, including the previously disclosed partial loss of a customer contract in the second quarter of 2014, and the effects of changing reimbursement patterns and rates of federal and state payers related to our government program eligibility and enrollment services.
Technology-enabled services adjusted EBITDA for the nine months ended September 30, 2015 decreased by $1.1 million, or 1.0%, as compared to the prior year period. As a percentage of solutions revenue, technology-enabled services adjusted EBITDA was 36.6% for the nine months ended September 30, 2015 as compared to 37.0% for the prior year period. The decrease in technology-enabled services adjusted EBITDA and as a percentage of solutions revenue was primarily due to the impact of the revenue items described above and changes in revenue mix.
Liquidity and Capital Resources
General
We are a holding company with no material business operations. Our principal assets are the equity interests we own in our subsidiaries. We conduct all of our business operations through our direct and indirect subsidiaries. Accordingly, our only material sources of cash are borrowings under our Senior Credit Facilities and dividends or other distributions or payments that are derived from earnings and cash flow generated by our subsidiaries.
We anticipate cash generated by operations, the funds available under our Senior Credit Facilities, including the Revolving Facility, and existing cash and equivalents will be sufficient to meet working capital requirements, service our debt and finance capital expenditures. There can be no assurance, however, that our business will generate sufficient cash flow from operations or that future borrowings will be available to us under our Senior Credit Facilities in amounts sufficient to enable us to repay our indebtedness, or to fund other liquidity needs.
49
We and our subsidiaries, affiliates or significant stockholders may from time to time seek to retire or purchase our outstanding debt (including our senior notes) through cash purchases and/or exchanges for equity securities, in open market purchases, privately negotiated transactions or otherwise. Such repurchases or exchanges, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. The amounts involved may be material.
Cash Flows
Operating Activities
Cash provided by operating activities for the nine months ended September 30, 2015 was $152.3 million as compared to $108.4 million for nine months ended September 30, 2014, an increase of $43.9 million. This increase is primarily due to business growth, the effects of acquisitions and the timing of collections and related disbursements.
Cash provided by operating activities can be significantly impacted by our non-cash working capital assets and liabilities, which may vary based on the timing of cash receipts that fluctuate by day of week and/or month and also may be impacted by cash management decisions.
Investing Activities
Cash used in investing activities for the nine months ended September 30, 2015 was $760.5 million as compared to $125.7 million for the nine months ended September 30, 2014. Cash used in investing activities for both such periods consisted of the effects of acquisitions and capital expenditures for property and equipment.
Financing Activities
Cash provided by financing activities for the nine months ended September 30, 2015 was $610.8 million as compared to cash used in financing activities of $35.3 million for the nine months ended September 30, 2014. Cash provided by financing activities for the nine months ended September 30, 2015 primarily consisted of borrowings under our Senior Credit Facilities and 2021 Notes and capital contributions to partially finance the Altegra acquisition, partially offset by principal payments under our Senior Credit Facilities and deferred financing arrangements. Cash used in financing activities for the nine months ended September 30, 2014 primarily consisted of principal payments under our Senior Credit Facilities and deferred financing arrangements.
Long-term Debt
Our long-term indebtedness is comprised of the Term Loan Facility, the Revolving Facility, $375.0 million of 11% senior notes due 2019 (the 2019 Notes), $375.0 million 11.25% senior notes due 2020 (the 2020 Notes) and the 2021 Notes; (together with the 2019 Notes and 2020 Notes, the Senior Notes).
Long-term debt as of September 30, 2015 and December 31, 2014, consisted of the following (amounts in thousands):
September 30, 2015 |
December 31, 2014 |
|||||||
Senior Credit Facilities |
||||||||
$1,696 million Senior Secured Term Loan facility, due November 2, 2018, net of unamortized discount of $25,499 and $20,016 at September 30, 2015 and December 31, 2014, respectively (effective interest rate of 4.29%) |
$ | 1,624,223 | $ | 1,245,376 | ||||
$160 million Senior Secured Term Loan facility, due November 2, 2018, net of unamortized discount of $3,615 and $4,438 at September 30, 2015 and December 31, 2014, respectively (effective interest rate of 4.54%) |
154,785 | 155,162 | ||||||
$125 million Senior Secured Revolving Credit facility, expiring on November 2, 2016 and bearing interest at a variable base rate plus a spread rate |
| |
50
Senior Notes |
||||||||
$375 million 11% Senior Notes due December 31, 2019, net of unamortized discount of $6,605 and $7,477 at September 30, 2015 and December 31, 2014, respectively (effective interest rate of 11.53%) |
368,395 | 367,523 | ||||||
$375 million 11.25% Senior Notes due December 31, 2020, net of unamortized discount of $8,778 and $9,651 at September 30, 2015 and December 31, 2014, respectively (effective interest rate of 11.85%) |
366,222 | 365,349 | ||||||
$250 million 6% Senior Notes due February 15, 2021, net of unamortized discount of $6,412 and $0 at September 30, 2015 and December 31, 2014, respectively (effective interest rate of 6.57%) |
243,588 | | ||||||
Obligation under data sublicense agreement |
17,237 | 17,237 | ||||||
Other |
7,145 | 12,129 | ||||||
Less current portion |
(31,265 | ) | (27,308 | ) | ||||
|
|
|
|
|||||
Long-term debt |
$ | 2,750,330 | $ | 2,135,468 | ||||
|
|
|
|
Senior Credit Facilities
The Senior Credit Agreement provides that, subject to certain conditions, we may request additional tranches of term loans, increase commitments under the Revolving Facility or the Term Loan Facility or add one or more incremental revolving credit facility tranches (provided that the revolving credit commitments outstanding at any time have no more than three different maturity dates) in an aggregate amount not to exceed (a) $300.0 million plus (b) an unlimited amount at any time, subject to compliance on a pro forma basis with a first lien net leverage ratio of no greater than 4.00 to 1.00. Availability of such additional tranches of term loans or revolving credit facilities and/or increased commitments is subject to, among other conditions, the absence of any default under the Senior Credit Agreement and the receipt of commitments by existing or additional financial institutions. Proceeds of the Revolving Facility, including up to $30.0 million in the form of borrowings on same-day notice, referred to as swingline loans, and up to $50.0 million in the form of letters of credit, are available to provide financing for working capital and general corporate purposes.
Borrowings under the Senior Credit Facilities bear interest at an annual rate equal to an applicable margin plus, at our option, either (a) a base rate determined by reference to the highest of (i) the applicable prime rate, (ii) the federal funds rate plus 0.50% and (iii) a LIBOR rate determined by reference to the costs of funds for United States dollar deposits for an interest period of one month, adjusted for certain additional costs, plus 1.00%, which base rate, in the case of the Term Loan Facility only, shall be no less than 2.25%, or (b) a LIBOR rate determined by reference to the costs of funds for United States dollar deposits for the interest period relevant to such borrowing, adjusted for certain additional costs, which, in the case of the Term Loan Facility only, shall be no less than 1.25%.
In April 2012, we amended the Senior Credit Agreement to reprice the Senior Credit Facilities and borrow $80.0 million of additional term loans. In April 2013, we again amended the Senior Credit Agreement to further reprice, and also to modify certain financial covenants under, the Senior Credit Facilities. Following the April 2013 amendment, the interest rate on both the Term Loan Facility and Revolving Facility is LIBOR plus 2.50%. The Term Loan Facility remains subject to a LIBOR floor of 1.25%, and there continues to be no LIBOR floor on the Revolving Facility. In connection with the April 2013 repricing, the Senior Credit Agreement also was amended to, among other things, eliminate the financial covenant related to the consolidated cash interest coverage ratio and modify the financial covenant related to the net leverage test by maintaining the required first lien net leverage ratio at 5.35 to 1.00 for the remaining term of the Senior Credit Facilities.
In December 2014 and August 2015, through further amendments to the Senior Credit Agreement, we borrowed an additional $160.0 million and $395.0 million, respectively, under incremental term loan facilities on identical terms and having the same rights and obligations as the existing term loans under the Senior Credit Agreement.
In addition to paying interest on outstanding principal under the Senior Credit Facilities, we are required to pay customary agency fees, letter of credit fees and a 0.50% commitment fee in respect of the unutilized commitments under the Revolving Facility.
The Senior Credit Agreement requires that we prepay outstanding loans under the Term Loan Facility, subject to certain exceptions, with (a) 100% of the net cash proceeds of any incurrence of debt other than debt permitted under the Senior Credit Agreement, (b) 50% (which percentage will be reduced to 25% and 0% based on our first lien net leverage ratio) of our annual excess cash flow and (c) 100% of the net cash proceeds of certain asset sales and casualty and condemnation events, subject to reinvestment rights and certain other exceptions.
51
We generally may voluntarily prepay outstanding loans under the Senior Credit Facilities at any time without premium or penalty other than breakage costs with respect to LIBOR loans.
We are required to make quarterly payments equal to 0.25% of the aggregate principal amount of the loans under the Term Loan Facility, with the balance due and payable on November 2, 2018. Any principal amount outstanding under the Revolving Facility is due and payable on November 2, 2016.
Certain of our United States wholly-owned restricted subsidiaries, together with the Company, are co-borrowers and jointly and severally liable for all obligations under the Senior Credit Facilities. Such obligations of the co-borrowers are unconditionally guaranteed by Beagle Intermediate Holdings, Inc., a direct wholly-owned subsidiary of Beagle Parent Corp., the Company and each of our existing and future United States wholly-owned restricted subsidiaries (with certain exceptions including immaterial subsidiaries). These obligations are secured by a perfected security interest in substantially all of the assets of the co-borrowers and guarantors now owned or later acquired, including a pledge of all of the capital stock of the Company and our United States wholly-owned restricted subsidiaries and 65% of the capital stock of our foreign restricted subsidiaries, subject in each case to the exclusion of certain assets and additional exceptions.
The Senior Credit Agreement requires us to comply with a maximum first lien net leverage ratio financial maintenance covenant, to be tested on the last day of each fiscal quarter. A breach of the first lien net leverage ratio covenant is subject to certain equity cure rights. In addition, the Senior Credit Facilities contain a number of negative covenants that, among other things and subject to certain exceptions, restrict our ability and the ability of our subsidiaries to:
| incur additional indebtedness or guarantees; |
| incur liens; |
| make investments, loans and acquisitions; |
| consolidate or merge; |
| sell assets, including capital stock of subsidiaries; |
| pay dividends on capital stock or redeem, repurchase or retire capital stock of the Company or any restricted subsidiary; |
| alter the business of the Company; |
| amend, prepay, redeem or purchase subordinated debt; |
| engage in transactions with affiliates; and |
| enter into agreements limiting dividends and distributions of certain subsidiaries. |
The Senior Credit Agreement also contains certain customary representations and warranties, affirmative covenants and provisions relating to events of default (including upon change of control).
As of September 30, 2015, we believe we were in compliance with all of the applicable debt covenants under the Senior Credit Agreement.
Senior Notes
The 2019 Notes bear interest at an annual rate of 11.00% with interest payable semi-annually on June 30 and December 31 of each year. The 2019 Notes mature on December 31, 2019. The 2020 Notes bear interest at an annual rate of 11.25% with interest payable quarterly on March 31, June 30, September 30 and December 31 of each year. The 2020 Notes mature on December 31, 2020. The 2021 Notes bear interest at an annual rate of 6.00% with interest payable semi-annually on April 15 and October 15 of each year, commencing on April 15, 2016. The 2021 Notes mature on February 15, 2021.
We may redeem the 2019 Notes, the 2020 Notes or both, in whole or in part, at any time on or after December 31, 2015 at the applicable redemption price, plus accrued and unpaid interest. At any time prior to December 31, 2015, we may redeem the 2019 Notes, the 2020 Notes or both, in whole or in part, at our option and on one or more occasions, at a redemption price equal to 100% of the principal amount, plus a make-whole premium and accrued and unpaid interest.
We may redeem the 2021 Notes, in whole or in part, at any time on or after August 15, 2017 at the applicable redemption price, plus accrued and unpaid interest. At any time prior to August 15, 2017, we may, at our option and on one or more occasions, redeem up to 40% of the aggregate principal amount of the 2021 Notes at a redemption price equal to
52
100% of the aggregate principal amount, plus a premium and accrued and unpaid interest with the net cash proceeds of certain equity offerings. At any time prior to August 15, 2017, we may redeem the 2021 Notes, in whole or in part, at its option and on one or more occasions, at a redemption price equal to 100% of the principal amount, plus a make-whole premium and accrued and unpaid interest.
If we experience specific kinds of changes in control, we must offer to purchase the Senior Notes at a purchase price equal to 101% of the principal amount, plus accrued and unpaid interest.
The Senior Notes are senior unsecured obligations and rank equally in right of payment with all of our existing and future indebtedness and senior in right of payment to all of our existing and future subordinated indebtedness. Our obligations under the Senior Notes are guaranteed on a senior basis by all of our existing and subsequently acquired or organized wholly-owned United States restricted subsidiaries that guarantee our Senior Credit Facilities or our other indebtedness or indebtedness of any affiliate guarantor. The Senior Notes and the related guarantees are effectively subordinated to our existing and future secured obligations and that of our affiliate guarantors to the extent of the value of the collateral securing such obligations, and are structurally subordinated to all existing and future indebtedness and other liabilities of any of our subsidiaries that do not guarantee the Senior Notes.
The indentures governing the Senior Notes (the Indentures) contain customary covenants that restrict our ability and the ability of our restricted subsidiaries to:
| pay dividends on our capital stock or redeem, repurchase or retire our capital stock, subject to customary exceptions, including compliance with a fixed charge coverage ratio and subject to limitation based on net income generated during the term of the Indentures; |
| incur additional indebtedness or issue certain capital stock; |
| incur certain liens; |
| make investments, loans, advances and acquisitions; |
| consolidate, merge or transfer all or substantially all of our assets and the assets of our subsidiaries; |
| prepay subordinated debt; |
| engage in certain transactions with our affiliates; and |
| enter into agreements restricting our subsidiaries ability to pay dividends. |
The Indentures also contain certain affirmative covenants and events of default.
As of September 30, 2015, we believe we were in compliance with all of the applicable debt covenants under the Senior Notes.
Off-Balance Sheet Arrangements
As of the filing of this Quarterly Report, we had no off-balance sheet arrangements or obligations, other than those related to surety bonds of an insignificant amount.
ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK |
We have interest rate risk primarily related to borrowings under the Senior Credit Agreement. Borrowings under the Senior Credit Facilities bear interest at an annual rate equal to an applicable margin plus, at our option, either (a) a base rate determined by reference to the highest of (i) the applicable prime rate, (ii) the federal funds rate plus 0.50% and (iii) a LIBOR rate determined by reference to the costs of funds for United States dollar deposits for an interest period of one month, adjusted for certain additional costs, plus 1.00%, which base rate, in the case of the Term Loan Facility only, shall be no less than 2.25% or (b) a LIBOR rate determined by reference to the costs of funds for United States dollar deposits for the interest period relevant to such borrowing, adjusted for certain additional costs, which, in the case of the Term Loan Facility only, shall be no less than 1.25%.
As of September 30, 2015, we had outstanding borrowings of $1,808.1 million (before unamortized debt discount) under the Senior Credit Agreement. As of September 30, 2015, the LIBOR-based interest rate on the Term Loan Facility and Revolving Facility were each LIBOR plus 2.50%. The Term Loan Facility is subject to a LIBOR floor of 1.25% and there is no LIBOR floor on the Revolving Facility.
53
We manage economic risks, including interest rate, liquidity and credit risk, primarily by managing the amount, sources and duration of our debt funding and the use of derivative financial instruments. Specifically, we enter into interest rate swap agreements to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. Our interest rate swap agreements are used to manage differences in the amount, timing and duration of our known or expected cash receipts and our known or expected cash payments principally related to our borrowings.
In January 2012, we executed three interest rate swap agreements with an aggregate notional amount of $640.0 million to reduce the variability of interest payments associated with the Term Loan Facility. For the nine months ended September 30, 2015, our interest rate swap agreements were designated as a cash flow hedge so that changes in the fair market value of the interest rate swap agreements were included within other comprehensive income.
A change in interest rates on variable rate debt may impact our pretax earnings and cash flows. However, due to a floor on the floating rate index of 1.25% under the Term Loan Facility, as of September 30, 2015, our interest rates must increase by more than 100 basis points before our interest expense or cash flows are affected. Based on our outstanding debt as of September 30, 2015, and assuming that our mix of debt instruments, interest rate swaps and other variables remain the same, the annualized effect of a one percentage point change in variable interest rates would have minimal impact on our earnings and cash flows.
In the future, in order to manage our interest rate risk, we may refinance our existing debt, enter into additional interest rate swap agreements, modify our existing interest rate swap agreements or make changes that may impact our ability to treat our interest rate swaps as a cash flow hedge. However, we do not intend or expect to enter into derivative or interest rate swap transactions for speculative purposes.
ITEM 4. | CONTROLS AND PROCEDURES |
Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures
Under the supervision and with the participation of our Chief Executive Officer (CEO) and Chief Financial Officer (CFO), management has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)) as of September 30, 2015. Based upon that evaluation, our CEO and CFO concluded that, as of September 30, 2015, our disclosure controls and procedures were effective to ensure that the information we are required to disclose in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There have been no changes to our internal control over financial reporting that occurred during the three months ended September 30, 2015, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II. OTHER INFORMATION
ITEM 1. | LEGAL PROCEEDINGS |
In the normal course of business, the Company is subject to claims, lawsuits and legal proceedings. While it is not possible to ascertain the ultimate outcome of such matters, in managements opinion, the liabilities, if any, in excess of amounts provided or covered by insurance, are not expected to have a material adverse effect on our consolidated financial position, results of operations or liquidity.
ITEM 1A. | RISK FACTORS |
In connection with the private offering of the 2021 Notes, the Company provided updated risk factors in a preliminary offering memorandum dated August 4, 2015. The updated risk factors that reflect the acquisition of Altegra and the incurrence of additional debt related to such acquisition have been filed as Exhibit 99.1 to this Quarterly Report and are incorporated herein by reference.
54
ITEM 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS |
None.
ITEM 3. | DEFAULTS UPON SENIOR SECURITIES |
None.
ITEM 4. | MINE SAFETY DISCLOSURES |
None.
ITEM 5. | OTHER INFORMATION |
None.
ITEM 6. | EXHIBITS |
The exhibits listed on the accompanying Exhibit Index are filed, furnished or incorporated by reference (as stated therein) as part of this Quarterly Report.
55
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
EMDEON INC. | ||||||||
Date: November 6, 2015 | By: | /s/ Neil E. de Crescenzo | ||||||
Neil E. de Crescenzo, President and Chief Executive Officer and Director | ||||||||
(Principal Executive Officer) | ||||||||
Date: November 6, 2015 | By: | /s/ Randy P. Giles | ||||||
Randy P. Giles, Chief Financial Officer | ||||||||
(Principal Financial Officer) | ||||||||
Date: November 6, 2015 | By: | /s/ Dennis B. Robbins | ||||||
Dennis B. Robbins, Chief Accounting Officer | ||||||||
(Principal Accounting Officer) |
56
Exhibit No. |
||
2.1 | Agreement and Plan of Merger, dated July 3, 2015, by and among MediFAX-EDI, LLC, Alto Merger Sub Inc., Altegra Health, Inc. and Parthenon Investors III, L.P., solely in its capacity as the Stockholders Representative (included as Exhibit 2.1 to the Companys Current Report on Form 8-K (File No. 1-34435), filed on July 9, 2015, and incorporated herein by reference). | |
4.1 | 2021 Notes Indenture, dated as of August 12, 2015, among Emdeon Inc., the guarantors party thereto and Wilmington Trust, National Association, as trustee (included as Exhibit 4.1 to the Companys Current Report on Form 8-K (File No. 1-34435), filed August 13, 2015, and incorporated herein by reference). | |
4.2 | 2021 Notes Supplemental Indenture, dated as of August 12, 2015, among Altegra Health, Inc., Altegra Health Operating Company, Altegra Health Operating CompanyPuerto Rico, LLC, Altegra Health Connections, LLC and Wilmington Trust, National Association, as trustee (included as Exhibit 4.2 to the Comapnys Current Report on Form 8-K (File No. 1-34435), filed August 13, 2015, and incorporated herein by reference). | |
4.3 | 2019 Notes Supplemental Indenture, dated as of August 12, 2015, among Altegra Health, Inc., Altegra Health Operating Company, Altegra Health Operating CompanyPuerto Rico, LLC, Altegra Health Connections, LLC and Wilmington Trust, National Association, as trustee (filed herewith). | |
4.4 | 2020 Notes Supplemental Indenture, dated as of August 12, 2015, among Altegra Health, Inc., Altegra Health Operating Company, Altegra Health Operating CompanyPuerto Rico, LLC, Altegra Health Connections, LLC and Wilmington Trust, National Association, as trustee (filed herewith). | |
10.1 | Amendment No. 4 to the Credit Agreement, dated as of August 12, 2015, among Emdeon Inc., the other borrowers party thereto, Bank of America, N.A., as administrative agent, swing line lender, letter of credit issuer and collateral agent thereunder, and the lenders, guarantors and agents party thereto (included as Exhibit 10.1 to the Companys Current Report on Form 8-K (File No. 1-34435), filed August 13, 2015, and incorporated herein by reference). | |
31.1 | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended (filed herewith). | |
31.2 | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended (filed herewith). | |
32.1 | Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith). | |
32.2 | Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith). | |
99.1 | Risk Factors (filed herewith). | |
101.INS | XBRL Instance Document | |
101.SCH | XBRL Taxonomy Extension Scheme Document | |
101.CAL | XBRL Taxonomy Calculation Linkbase Document | |
101.DEF | XBRL Taxonomy Definition Linkbase Document | |
101.LAB | XBRL Taxonomy Label Linkbase Document | |
101.PRE | XBRL Taxonomy Presentation Linkbase Document |
57